<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="dar14008" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Alcohol Rev</journal-id><journal-id journal-id-type="iso-abbrev">Drug Alcohol Rev</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">DAR</journal-id><journal-title-group><journal-title>Drug and Alcohol Review</journal-title></journal-title-group><issn pub-type="ppub">0959-5236</issn><issn pub-type="epub">1465-3362</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11886497</article-id><article-id pub-id-type="pmcid-ver">PMC11886497.1</article-id><article-id pub-id-type="pmcaid">11886497</article-id><article-id pub-id-type="pmcaiid">11886497</article-id><article-id pub-id-type="pmid">39932804</article-id><article-id pub-id-type="doi">10.1111/dar.14008</article-id><article-id pub-id-type="publisher-id">DAR14008</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Original Paper</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Unmet treatment need: The size of the gap for alcohol and other drugs in Australia</article-title><alt-title alt-title-type="right-running-head">Unmet demand in <styled-content style="fixed-case" toggle="no">AOD</styled-content> treatment</alt-title><alt-title alt-title-type="left-running-head">Ritter and O'Reilly</alt-title></title-group><contrib-group><contrib id="dar14008-cr-0001" contrib-type="author"><name name-style="western"><surname>Ritter</surname><given-names initials="A">Alison</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9540-1920</contrib-id><xref rid="dar14008-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="dar14008-cr-0002" contrib-type="author" corresp="yes"><name name-style="western"><surname>O'Reilly</surname><given-names initials="K">Keelin</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5361-2316</contrib-id><xref rid="dar14008-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>k.oreilly@unsw.edu.au</email></address></contrib></contrib-group><aff id="dar14008-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Drug Policy Modelling Program, Social Policy Research Centre</named-content>
<institution>UNSW Sydney</institution>
<city>Sydney</city>
<country country="AU">Australia</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Keelin O'Reilly, Room 121, John Goodsell Building (F20), Library Rd, UNSW Sydney, Kensington, NSW 2052, Australia.<break/>
Email: <email>k.oreilly@unsw.edu.au</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2025</year></pub-date><volume>44</volume><issue seq="140">3</issue><issue-id pub-id-type="pmc-issue-id">483646</issue-id><issue-id pub-id-type="doi">10.1111/dar.v44.3</issue-id><fpage>772</fpage><lpage>782</lpage><history><date date-type="rev-recd"><day>05</day><month>1</month><year>2025</year></date><date date-type="received"><day>15</day><month>8</month><year>2024</year></date><date date-type="accepted"><day>15</day><month>1</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>07</day><month>03</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>08</day><month>03</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-08 00:25:31.810"><day>08</day><month>03</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2025 The Author(s). <italic toggle="yes">Drug and Alcohol Review</italic> published by John Wiley &amp; Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="DAR-44-772.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:DAR-44-772.pdf"/><abstract><title>Abstract</title><sec id="dar14008-sec-0001"><title>Introduction</title><p>Assessing unmet demand for alcohol and other drug (AOD) treatment requires accurately counting those in treatment and determining those in need of treatment. Using updated epidemiological and treatment data, this study sought to provide an updated estimate of the unmet demand for AOD treatment in Australia.</p></sec><sec id="dar14008-sec-0002"><title>Methods</title><p>Australian prevalence rates for alcohol, cannabis, methamphetamine and opioid use disorders were obtained from the Global Burden of Disease and research studies. The estimated proportion of people who would likely not seek or need treatment were subtracted from the diagnosed population. The number of people receiving treatment was estimated using AOD treatment databases and previous research.</p></sec><sec id="dar14008-sec-0003"><title>Results</title><p>An estimated 752,812 to 1,291,119 people met criteria for a substance use disorder in Australia in 2023. Removing the proportion of people who would not need or seek treatment resulted in between 406,697 and 668,497 people as the potential treatment population. The number of people who received treatment in Australia was estimated at 198,731 people. The unmet demand for AOD treatment was estimated to be between 207,966 and 469,767 in 2023.</p></sec><sec id="dar14008-sec-1003"><title>Discussion and Conclusions</title><p>In Australia, we only treat between 30% and 48% of the population who would seek and benefit from AOD treatment. This is a conservative analysis that assumes only 40% of the alcohol and cannabis use disorder population would seek treatment. The findings from this analysis highlight the continued significant unmet treatment needs of people with substance use disorders. Treatment resources need to be doubled in order to address this unmet treatment population.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="dar14008-kwd-0001">alcohol</kwd><kwd id="dar14008-kwd-0002">drugs</kwd><kwd id="dar14008-kwd-0003">healthcare planning</kwd><kwd id="dar14008-kwd-0004">treatment demand</kwd><kwd id="dar14008-kwd-0005">treatment need</kwd></kwd-group><counts><fig-count count="0"/><table-count count="15"/><page-count count="11"/><word-count count="6800"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:07.03.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="dar14008-cit-9001"><string-name name-style="western"><surname>Ritter</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>O'Reilly</surname><given-names>K</given-names></string-name>. <article-title>Unmet treatment need: The size of the gap for alcohol and other drugs in Australia</article-title>. <source>Drug Alcohol Rev</source>. <year>2025</year>;<volume>44</volume>(<issue>3</issue>):<fpage>772</fpage>&#8211;<lpage>782</lpage>. <pub-id pub-id-type="doi">10.1111/dar.14008</pub-id><pub-id pub-id-type="pmid">39932804</pub-id><pub-id pub-id-type="pmcid">PMC11886497</pub-id></mixed-citation>
</p></notes></front><body id="dar14008-body-0001"><p>
<boxed-text position="anchor" content-type="box" id="dar14008-blkfxd-0001" orientation="portrait"><caption><title>Key Points</title></caption><p>
<list list-type="bullet" id="dar14008-list-0001"><list-item id="dar14008-li-0001"><p>Previous analyses of the size of the alcohol and other drug (AOD) treatment gap in Australia are outdated, given epidemiological changes and better treatment data. This study sought to provide an up&#8208;to&#8208;date estimate of the size of unmet demand for AOD treatment in Australia.</p></list-item><list-item id="dar14008-li-0002"><p>With 198,731 people receiving AOD treatment in Australia in 2023, this represents between 30% and 48% of the population who would seek treatment.</p></list-item><list-item id="dar14008-li-0003"><p>Between 207,966 and 469,767 people missed out on AOD treatment in Australia in 2023.</p></list-item><list-item id="dar14008-li-0004"><p>The findings from this analysis highlight the continued significant unmet demand for treatment of people with substance use disorders.</p></list-item><list-item id="dar14008-li-0005"><p>Treatment resources need to be doubled in order to address this unmet treatment population.</p></list-item></list>
</p></boxed-text>
</p><sec id="dar14008-sec-0006"><label>1</label><title>INTRODUCTION</title><p>People who receive alcohol or other drug (AOD) treatment represent a very small proportion of all people diagnosed with a substance use disorder (SUD) [<xref rid="dar14008-bib-0001" ref-type="bibr">1</xref>, <xref rid="dar14008-bib-0002" ref-type="bibr">2</xref>, <xref rid="dar14008-bib-0003" ref-type="bibr">3</xref>, <xref rid="dar14008-bib-0004" ref-type="bibr">4</xref>, <xref rid="dar14008-bib-0005" ref-type="bibr">5</xref>]. This &#8216;unmet need&#8217; population has been estimated for many countries and, while the findings vary by country, they are consistently and staggeringly high, with the proportion who do receive treatment rarely exceeding 15% [<xref rid="dar14008-bib-0003" ref-type="bibr">3</xref>, <xref rid="dar14008-bib-0006" ref-type="bibr">6</xref>, <xref rid="dar14008-bib-0007" ref-type="bibr">7</xref>]. For example, there was a reported 12% treatment access rate in Singapore [<xref rid="dar14008-bib-0008" ref-type="bibr">8</xref>], 8&#8211;13% in the United States [<xref rid="dar14008-bib-0001" ref-type="bibr">1</xref>, <xref rid="dar14008-bib-0009" ref-type="bibr">9</xref>, <xref rid="dar14008-bib-0010" ref-type="bibr">10</xref>], 4% in Lesotho [<xref rid="dar14008-bib-0011" ref-type="bibr">11</xref>] and about 16% in Germany [<xref rid="dar14008-bib-0012" ref-type="bibr">12</xref>]. One systematic review found an average of 17% of people with alcohol use disorder accessed treatment in the past year across 25 different countries [<xref rid="dar14008-bib-0013" ref-type="bibr">13</xref>]. Australia has a reportedly similar low rate of treatment access; the 2020&#8211;2022 National Study of Mental Health and Wellbeing [<xref rid="dar14008-bib-0014" ref-type="bibr">14</xref>] shows that 9.5% of people with any SUD reported accessing professional treatment for AOD in the past year, mirroring international findings.</p><p>These figures, suggesting that around 80% to 90% of people with a diagnosed SUD do not receive treatment, are very confronting for governments seeking to plan and fund AOD treatments. The overwhelming size of the unmet need population has the potential to impede effective treatment scale&#8208;up. At the same time, these figures may not be the best representation of the size of the treatment gap. Importantly, many people with SUD recover without any formal treatment [<xref rid="dar14008-bib-0015" ref-type="bibr">15</xref>, <xref rid="dar14008-bib-0016" ref-type="bibr">16</xref>, <xref rid="dar14008-bib-0017" ref-type="bibr">17</xref>, <xref rid="dar14008-bib-0018" ref-type="bibr">18</xref>]. While this varies by drug type and study design, it may be as high as 63% of the remitted population for alcohol [<xref rid="dar14008-bib-0019" ref-type="bibr">19</xref>] and 56% for cannabis [<xref rid="dar14008-bib-0015" ref-type="bibr">15</xref>]. In addition, if the above unmet need estimates only count those who receive AOD treatment within a specialist AOD setting, they are likely to under&#8208;count treatment delivered. For example, many people receive help with their AOD problems from mental health services, primary care services and other non&#8208;AOD treatment services and settings [<xref rid="dar14008-bib-0020" ref-type="bibr">20</xref>, <xref rid="dar14008-bib-0021" ref-type="bibr">21</xref>].</p><p>A more careful approach to counting the number of people who do receive treatment, alongside adjustments to the population in need of treatment to reflect recovery without formal treatment and treatment seeking intentions, will result in more robust estimates of the size of the population who miss out on AOD treatment. We previously conducted such analyses for Australia [<xref rid="dar14008-bib-0004" ref-type="bibr">4</xref>, <xref rid="dar14008-bib-0022" ref-type="bibr">22</xref>], finding that rather than a gap of 80% to 90%, it was in the order of 44% to 74%. This suggested that we were treating around half the number of people suitable for treatment in Australia. Those analyses used SUD rates from 1997 for alcohol and cannabis, 2005 for amphetamines, and 2009 for opioids. Over the last 20&#8208;years, there have been significant changes in the nature and patterns of substance use across Australia. For example, there has been a reduction in alcohol consumption amongst young people in Australia between 2001 and 2022/2023 [<xref rid="dar14008-bib-0023" ref-type="bibr">23</xref>], methamphetamine use and harms have steadily increased over the past 10&#8208;years [<xref rid="dar14008-bib-0024" ref-type="bibr">24</xref>], and amphetamines have overtaken cannabis as the second most common principal drug of concern at AOD treatment services [<xref rid="dar14008-bib-0025" ref-type="bibr">25</xref>].</p><p>In addition, the AOD treatment environment has changed considerably since that time. Estimates suggest spending on treatment has increased, including as a proportion of total spending on illicit drug policy [<xref rid="dar14008-bib-0026" ref-type="bibr">26</xref>]. Finally, to date the work on unmet need and demand for treatment has not taken into consideration the important role that brief interventions can play in preventing future treatment&#8208;seeking. Screening and brief interventions have been shown to be efficacious and cost&#8208;effective for alcohol [<xref rid="dar14008-bib-0027" ref-type="bibr">27</xref>, <xref rid="dar14008-bib-0028" ref-type="bibr">28</xref>, <xref rid="dar14008-bib-0029" ref-type="bibr">29</xref>] though there are mixed findings for the efficacy for other drugs [<xref rid="dar14008-bib-0030" ref-type="bibr">30</xref>].</p><p>In this paper, we report new estimates for the size of the gap between the population of people meeting diagnostic criteria for an SUD who would be suitable for and likely to seek treatment, compared to the number of people who currently receive AOD treatment in Australia. We conduct separate analyses for alcohol, cannabis, methamphetamine and opioid use disorders, and include an estimate for brief interventions delivered to those with an SUD who do not receive comprehensive treatment.</p></sec><sec sec-type="methods" id="dar14008-sec-0007"><label>2</label><title>METHODS</title><p>Australian diagnostic prevalence rates for alcohol and cannabis use disorders were drawn from the 2021 Global Burden of Disease (GBD) study [<xref rid="dar14008-bib-0031" ref-type="bibr">31</xref>] in 5&#8208;year age increments, which we matched to 2023 Australian population estimates for people aged over 10&#8201;years from the Australian Bureau of Statistics [<xref rid="dar14008-bib-0032" ref-type="bibr">32</xref>]. Methamphetamine use disorder prevalence rates, for those 15&#8201;years and older, were also sourced from the Australian GBD data and matched to 5&#8208;year age increments. For opioids, and in light of the low population prevalence we used a more specific data source [<xref rid="dar14008-bib-0033" ref-type="bibr">33</xref>], which provided the prevalence of opioid use disorders in Sydney, Australia for 15 to 64&#8201;year olds. The rates from Downing et al. [<xref rid="dar14008-bib-0033" ref-type="bibr">33</xref>] are 1.7 to 2.1 times higher than those provided by GBD. As the authors acknowledge, their estimates are higher than previously published in both household surveys and indirect estimations due to more advanced and comprehensive epidemiological methods [<xref rid="dar14008-bib-0033" ref-type="bibr">33</xref>]. The prevalence rates are provided in Table&#160;<xref rid="dar14008-tbl-0009" ref-type="table">A1</xref>.</p><p>Both the GBD [<xref rid="dar14008-bib-0031" ref-type="bibr">31</xref>] and Downing et al. [<xref rid="dar14008-bib-0033" ref-type="bibr">33</xref>] provide a main estimate and an upper and lower confidence interval estimate for the prevalence of SUD. In the analysis, we therefore report three estimates (main, lower and upper) for the number of people who should receive treatment, paralleling these differing prevalence estimates.</p><p>In order to take into account recovery in the absence of treatment, and the proportion of people who would not seek treatment for their SUD, we triangulated two different data sources: published research on rates of &#8216;natural recovery&#8217; or &#8216;spontaneous remission&#8217;, and data on intentions to seek help. In relation to the former, for alcohol, an average of 50% of people in remission are likely to resolve their alcohol use disorder in the absence of treatment [<xref rid="dar14008-bib-0019" ref-type="bibr">19</xref>].<xref rid="dar14008-note-0015" ref-type="fn">
<sup>1</sup>
</xref> For cannabis, research suggests average remission rates are about 55&#8211;65% [<xref rid="dar14008-bib-0015" ref-type="bibr">15</xref>, <xref rid="dar14008-bib-0034" ref-type="bibr">34</xref>], of which about half resolve their cannabis issues without treatment [<xref rid="dar14008-bib-0017" ref-type="bibr">17</xref>, <xref rid="dar14008-bib-0035" ref-type="bibr">35</xref>]. Methamphetamine use disorder appears to have much lower rates of natural remission compared to alcohol or cannabis [<xref rid="dar14008-bib-0016" ref-type="bibr">16</xref>, <xref rid="dar14008-bib-0035" ref-type="bibr">35</xref>, <xref rid="dar14008-bib-0036" ref-type="bibr">36</xref>]. One Australian study found 18% of people who were methamphetamine dependent remitted without any professional treatment at 12&#8208;month follow up [<xref rid="dar14008-bib-0016" ref-type="bibr">16</xref>].</p><p>For opioids, there was limited research on natural recovery or spontaneous remission. One US study found about 70% of people who remitted from an opioid use disorder utilised some form of treatment, but did not measure what proportion of people remit [<xref rid="dar14008-bib-0035" ref-type="bibr">35</xref>]. Previous research has found low rates of remission for opioid use disorder in a 3&#8208;year period at approximately 40% [<xref rid="dar14008-bib-0037" ref-type="bibr">37</xref>]. These findings suggest most people with an opioid use disorder will require some form of treatment, notably opioid agonist therapy.</p><p>Turning to data on intentions to seek help, the National Study of Mental Health and Wellbeing (NSMHWB) asked people whether they perceived a need for mental health services (&#8220;Whether perceived need for information on mental health was met&#8221;). While not a perfect match for treatment seeking intentions because it is not specific to AOD treatment, it is a reasonable proxy. For those people meeting criteria for alcohol use disorder, 51.8% did not perceive a need for treatment [<xref rid="dar14008-bib-0014" ref-type="bibr">14</xref>]. For the more generic category of SUD, it was 50.4%. These data are provided in Tables&#160;<xref rid="dar14008-tbl-0010" ref-type="table">A2</xref>, <xref rid="dar14008-tbl-0011" ref-type="table">A3</xref>, <xref rid="dar14008-tbl-0012" ref-type="table">A4</xref>.</p><p>Triangulating the above two sources of information, it suggests that an appropriate treatment rate to apply to the population prevalence for alcohol use disorder is 40%. The same proportion (40%) is applied to the cannabis use disorder population. For methamphetamines, a lower number is likely to recover without treatment compared to alcohol and cannabis, and the NSMHWB does not provide a directly comparable figure for intentions to seek help. In the absence of further data, we assume that 75% of people with methamphetamine use disorder are likely to seek treatment. Finally for opioid use disorder, there are very limited data to suggest an appropriate treatment rate. For this work, we assume we should treat 90% of the diagnosed population.</p><p>This method to determine the percentages of the diagnosed population who would seek treatment has been used in previously published work [<xref rid="dar14008-bib-0004" ref-type="bibr">4</xref>, <xref rid="dar14008-bib-0038" ref-type="bibr">38</xref>, <xref rid="dar14008-bib-0039" ref-type="bibr">39</xref>]. Furthermore, the above percentages accord with expert consensus around Australia. The final rates of people who should receive treatment and the associated sources are provided in Table&#160;<xref rid="dar14008-tbl-0013" ref-type="table">A5</xref>.</p><p>That many people who meet diagnostic criteria for SUD (60% for alcohol and for cannabis) are not presumed to seek treatment in this analysis raises public health concerns. The opportunity to provide a single session brief intervention (most likely in a non&#8208;specialist setting) is an opportunity to provide information about seeking treatment, harm reduction advice and any other health or social supports. This recognises that while not everyone who meets diagnostic criteria will want or seek formal, professional AOD treatment, they likely still have other unmet health and wellbeing needs. We refer to this as a brief intervention but recognise there is insufficient evidence on whether brief interventions are effective for people with a SUD (as opposed to those at&#8208;risk) [<xref rid="dar14008-bib-0030" ref-type="bibr">30</xref>]. In addition, this modelling work aims to inform governments and the pragmatic context of government funding is such that treatment availability will never match full demand (like any other health service). The inclusion of brief interventions for those with SUD recognises this reality. To that end, we model the number of people meeting SUD criteria who could be suitable for a brief intervention in the absence of formal treatment.</p><p>Turning to the methods for estimating the number of people who did receive AOD treatment, in 2023, we accessed the two main existing databases on AOD treatment in Australia: the Alcohol and Other Drug Treatment Services National Minimum Dataset (AODTS&#8208;NMDS) and the National Opioid Pharmacotherapy Statistics Annual Dataset (NOPSAD). The AODTS&#8208;NMDS, published annually, counts all specialist AOD treatment provided through services that receive government funding [<xref rid="dar14008-bib-0025" ref-type="bibr">25</xref>]. This includes government run services, non&#8208;government organisations (that receive government funding) and some outpatient hospital services.</p><p>The NOPSAD is a census&#8208;based data collection, that counts the number of people who received opioid agonist therapy in Australia in different settings (e.g., public clinics, specialist AOD services, prisons). The data are collected on a snapshot day in June and the numbers are adjusted to reflect those that receive weekly or monthly medications.</p><p>These two datasets provide comprehensive data for the bulk of AOD treatment provided in Australia. However, there are other providers of AOD treatment not necessarily included within these two datasets, including general practitioners, allied health practitioners, Aboriginal Community Controlled Organisations, and private psychologists and psychiatrists. There are no routine administrative datasets that count AOD treatment in these settings. We relied on a previous research study [<xref rid="dar14008-bib-0020" ref-type="bibr">20</xref>] which counted all AOD treatment across these settings, in addition to the AODTS&#8208;NMDS and NOPSAD at that time. We calculated the ratio that these other settings comprised of the total treated population in that study (as detailed in Tables&#160;<xref rid="dar14008-tbl-0014" ref-type="table">A6</xref>, <xref rid="dar14008-tbl-0015" ref-type="table">A7</xref>). The total number of clients receiving treatment across all settings was 1.6 times that provided in the two main datasets alone (see Tables&#160;<xref rid="dar14008-tbl-0014" ref-type="table">A6</xref>, <xref rid="dar14008-tbl-0015" ref-type="table">A7</xref>). We applied this multiplier to the current 2023 data, to derive an estimated number of people receiving treatment across all settings for 2023. We tested the reliability of the treatment utilisation numbers against the estimates from the NSMHWB (as reported in the Results). This method includes the allied health and general practice providers outlined above but excludes non&#8208;professional or informal types of care such as mutual aid or 12&#8208;steps support groups.</p></sec><sec sec-type="results" id="dar14008-sec-0008"><label>3</label><title>RESULTS</title><p>The number of people estimated to have an SUD for the modelled substances (low, mid and high estimate) in Australia for 2022/2023 is shown in Table&#160;<xref rid="dar14008-tbl-0001" ref-type="table">1</xref>.</p><table-wrap position="float" id="dar14008-tbl-0001" content-type="TABLE" orientation="portrait"><label>TABLE 1</label><caption><p>Estimated number of people with a substance use disorder in Australia, 2022/2023.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Drug type</th><th align="left" valign="bottom" rowspan="1" colspan="1">Low prevalence estimate</th><th align="left" valign="bottom" rowspan="1" colspan="1">Mid prevalence estimate</th><th align="left" valign="bottom" rowspan="1" colspan="1">High prevalence estimate</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcohol<xref rid="dar14008-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">398,244</td><td align="left" valign="top" rowspan="1" colspan="1">543,189</td><td align="left" valign="top" rowspan="1" colspan="1">719,841</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cannabis<xref rid="dar14008-note-0002" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">116,835</td><td align="left" valign="top" rowspan="1" colspan="1">158,328</td><td align="left" valign="top" rowspan="1" colspan="1">210,002</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Amphetamines<xref rid="dar14008-note-0003" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">88,626</td><td align="left" valign="top" rowspan="1" colspan="1">133,888</td><td align="left" valign="top" rowspan="1" colspan="1">190,589</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Opioids<xref rid="dar14008-note-0004" ref-type="table-fn">
<sup>c</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">149,106</td><td align="left" valign="top" rowspan="1" colspan="1">159,031</td><td align="left" valign="top" rowspan="1" colspan="1">170,687</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="left" valign="top" rowspan="1" colspan="1">752,812</td><td align="left" valign="top" rowspan="1" colspan="1">994,436</td><td align="left" valign="top" rowspan="1" colspan="1">1,291,119</td></tr></tbody></table><table-wrap-foot id="dar14008-ntgp-0001"><fn id="dar14008-note-0001"><p>
<italic toggle="yes">Note</italic>: The different estimates are derived from the different estimates from the prevalence data. The low and high estimates represent the upper and lower confidence intervals.</p></fn><fn id="dar14008-note-0002"><label>
<sup>a</sup>
</label><p>Inclusive of people aged 10 and over. <italic toggle="yes">Source</italic>: <xref rid="dar14008-bib-0031" ref-type="bibr">31</xref>.</p></fn><fn id="dar14008-note-0003"><label>
<sup>b</sup>
</label><p>Inclusive of people aged 15 and over. <italic toggle="yes">Source</italic>: <xref rid="dar14008-bib-0031" ref-type="bibr">31</xref>.</p></fn><fn id="dar14008-note-0004"><label>
<sup>c</sup>
</label><p>Inclusive of people aged 15&#8211;64. <italic toggle="yes">Source</italic>: <xref rid="dar14008-bib-0033" ref-type="bibr">33</xref>.</p></fn></table-wrap-foot></table-wrap><p>There are an estimated 752,812 to 1,291,119 people aged 10 and over who meet criteria for a SUD in Australia, for 2022/2023.</p><p>Removing the proportion of people who would remit without treatment and/or will not seek treatment (60% for alcohol and cannabis; 25% for methamphetamines, and 10% for opioids), results in between 406,697 and 668,497 people who should receive treatment in 2022/2023 (see Table&#160;<xref rid="dar14008-tbl-0002" ref-type="table">2</xref>).</p><table-wrap position="float" id="dar14008-tbl-0002" content-type="TABLE" orientation="portrait"><label>TABLE 2</label><caption><p>Estimated number of people who should receive treatment for a substance use disorder in Australia, 2022/2023.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Drug type</th><th align="left" valign="bottom" rowspan="1" colspan="1">Low prevalence treatment number</th><th align="left" valign="bottom" rowspan="1" colspan="1">Mid prevalence treatment number</th><th align="left" valign="bottom" rowspan="1" colspan="1">High prevalence treatment number</th><th align="left" valign="bottom" rowspan="1" colspan="1">Proportion of the diagnosed population</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcohol<xref rid="dar14008-note-0006" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">159,298</td><td align="left" valign="top" rowspan="1" colspan="1">217,276</td><td align="left" valign="top" rowspan="1" colspan="1">287,936</td><td align="left" valign="top" rowspan="1" colspan="1">40.0%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cannabis<xref rid="dar14008-note-0006" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">46,734</td><td align="left" valign="top" rowspan="1" colspan="1">63,331</td><td align="left" valign="top" rowspan="1" colspan="1">84,001</td><td align="left" valign="top" rowspan="1" colspan="1">40.0%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Amphetamines<xref rid="dar14008-note-0007" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">66,470</td><td align="left" valign="top" rowspan="1" colspan="1">100,416</td><td align="left" valign="top" rowspan="1" colspan="1">142,942</td><td align="left" valign="top" rowspan="1" colspan="1">75.0%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Opioids<xref rid="dar14008-note-0008" ref-type="table-fn">
<sup>c</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">134,195</td><td align="left" valign="top" rowspan="1" colspan="1">143,128</td><td align="left" valign="top" rowspan="1" colspan="1">153,618</td><td align="left" valign="top" rowspan="1" colspan="1">90.0%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="left" valign="top" rowspan="1" colspan="1">406,697</td><td align="left" valign="top" rowspan="1" colspan="1">524,151</td><td align="left" valign="top" rowspan="1" colspan="1">668,497</td><td align="left" valign="top" rowspan="1" colspan="1">&#8208;</td></tr></tbody></table><table-wrap-foot id="dar14008-ntgp-0002"><fn id="dar14008-note-0005"><p>
<italic toggle="yes">Note</italic>: The different estimates are derived from the different estimates from the prevalence data. The low and high estimates represent the upper and lower confidence intervals.</p></fn><fn id="dar14008-note-0006"><label>
<sup>a</sup>
</label><p>Inclusive of people aged 10 and over.</p></fn><fn id="dar14008-note-0007"><label>
<sup>b</sup>
</label><p>Inclusive of people aged 15 and over.</p></fn><fn id="dar14008-note-0008"><label>
<sup>c</sup>
</label><p>Inclusive of people aged 15&#8211;64.</p></fn></table-wrap-foot></table-wrap><p>For the remaining individuals, those who meet diagnostic criteria but are outside the proportion of people modelled to receive treatment, a brief intervention is a sensible public health measure. The number of people modelled to receive brief intervention is provided in Table&#160;<xref rid="dar14008-tbl-0003" ref-type="table">3</xref>.</p><table-wrap position="float" id="dar14008-tbl-0003" content-type="TABLE" orientation="portrait"><label>TABLE 3</label><caption><p>Estimated number of people who should receive a brief intervention for a substance use disorder in Australia, 2022/2023.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Drug type</th><th align="left" valign="bottom" rowspan="1" colspan="1">Low prevalence treatment number</th><th align="left" valign="bottom" rowspan="1" colspan="1">Mid prevalence treatment number</th><th align="left" valign="bottom" rowspan="1" colspan="1">High prevalence treatment number</th><th align="left" valign="bottom" rowspan="1" colspan="1">Proportion of the diagnosed population</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcohol</td><td align="left" valign="top" rowspan="1" colspan="1">238,947</td><td align="left" valign="top" rowspan="1" colspan="1">325,914</td><td align="left" valign="top" rowspan="1" colspan="1">431,904</td><td align="left" valign="top" rowspan="1" colspan="1">60.0%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cannabis</td><td align="left" valign="top" rowspan="1" colspan="1">70,101</td><td align="left" valign="top" rowspan="1" colspan="1">94,997</td><td align="left" valign="top" rowspan="1" colspan="1">126,001</td><td align="left" valign="top" rowspan="1" colspan="1">60.0%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Amphetamines</td><td align="left" valign="top" rowspan="1" colspan="1">22,157</td><td align="left" valign="top" rowspan="1" colspan="1">33,472</td><td align="left" valign="top" rowspan="1" colspan="1">47,647</td><td align="left" valign="top" rowspan="1" colspan="1">25.0%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Opioids</td><td align="left" valign="top" rowspan="1" colspan="1">14,911</td><td align="left" valign="top" rowspan="1" colspan="1">15,903</td><td align="left" valign="top" rowspan="1" colspan="1">17,069</td><td align="left" valign="top" rowspan="1" colspan="1">10.0%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="left" valign="top" rowspan="1" colspan="1">346,115</td><td align="left" valign="top" rowspan="1" colspan="1">470,285</td><td align="left" valign="top" rowspan="1" colspan="1">622,622</td><td align="left" valign="top" rowspan="1" colspan="1">&#8208;</td></tr></tbody></table><table-wrap-foot id="dar14008-ntgp-0003"><fn id="dar14008-note-0009"><p>
<italic toggle="yes">Note</italic>: The different estimates are derived from the different estimates from the prevalence data. The low and high estimates represent the upper and lower confidence intervals.</p></fn></table-wrap-foot></table-wrap><p>An estimated 346,115 to 622,5622 people should receive a brief intervention for a substance use disorder in 2022/2023.</p><p>The primary estimate of the number of people actually receiving AOD treatment in Australia in 2022/2023 is 198,731. This is shown in Table&#160;<xref rid="dar14008-tbl-0004" ref-type="table">4</xref>.</p><table-wrap position="float" id="dar14008-tbl-0004" content-type="TABLE" orientation="portrait"><label>TABLE 4</label><caption><p>Estimated number of people receiving treatment in all settings, 2022/2023.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Drug type</th><th align="left" valign="bottom" rowspan="1" colspan="1">Clients in NOPSAD and AODTS</th><th align="left" valign="bottom" rowspan="1" colspan="1">Clients in other settings</th><th align="left" valign="bottom" rowspan="1" colspan="1">Total</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcohol</td><td align="left" valign="top" rowspan="1" colspan="1">40,083</td><td align="left" valign="top" rowspan="1" colspan="1">23,248</td><td align="left" valign="top" rowspan="1" colspan="1">63,330</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cannabis</td><td align="left" valign="top" rowspan="1" colspan="1">24,017</td><td align="left" valign="top" rowspan="1" colspan="1">13,930</td><td align="left" valign="top" rowspan="1" colspan="1">37,947</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Amphetamines</td><td align="left" valign="top" rowspan="1" colspan="1">22,870</td><td align="left" valign="top" rowspan="1" colspan="1">13,264</td><td align="left" valign="top" rowspan="1" colspan="1">36,134</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Opioids</td><td align="left" valign="top" rowspan="1" colspan="1">61,320</td><td align="left" valign="top" rowspan="1" colspan="1">&#8208;</td><td align="left" valign="top" rowspan="1" colspan="1">61,320</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="left" valign="top" rowspan="1" colspan="1">148,289</td><td align="left" valign="top" rowspan="1" colspan="1">50,442</td><td align="left" valign="top" rowspan="1" colspan="1">198,731</td></tr></tbody></table><table-wrap-foot id="dar14008-ntgp-0004"><fn id="dar14008-note-0010"><p>
<italic toggle="yes">Note</italic>: We assume the majority of clients receiving treatment for an opioid use disorder are counted in NOPSAD, therefore we do not account for clients receiving treatment for opioids in other settings.</p></fn><fn id="dar14008-note-0011"><p>Abbreviations: AODTS, Alcohol and Other Drug Treatment Services; NOPSAD, National Opioid Pharmacotherapy Statistics Annual Dataset.</p></fn></table-wrap-foot></table-wrap><p>We tested the reliability of this figure (198,731) against NSMWHB data. The NSMHWB provided the proportion of the sample self&#8208;reporting accessing AOD treatment in the past year who met diagnostic criteria for an SUD [<xref rid="dar14008-bib-0014" ref-type="bibr">14</xref>]. Converting our estimate of treatment utilisation into a proportion of the diagnosed population, Table&#160;<xref rid="dar14008-tbl-0005" ref-type="table">5</xref> shows that the results we obtained on treatment utilisation are very similar to those reported in the NSMHWB providing confidence in our estimates.</p><table-wrap position="float" id="dar14008-tbl-0005" content-type="TABLE" orientation="portrait"><label>TABLE 5</label><caption><p>Proportion of people with a substance use disorder who received treatment for alcohol and other drugs, comparison of our estimate with the National Study of Mental Health and Wellbeing (NSMHWB).</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th rowspan="2" align="left" valign="bottom" colspan="1">Drug type</th><th colspan="2" align="left" valign="bottom" rowspan="1">Proportion of diagnosed population who received treatment</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Our estimate (mid estimate)</th><th align="left" valign="bottom" rowspan="1" colspan="1">NSMHWB estimate</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcohol</td><td align="left" valign="top" rowspan="1" colspan="1">11.7%</td><td align="left" valign="top" rowspan="1" colspan="1">13.7%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Other drugs</td><td align="left" valign="top" rowspan="1" colspan="1">29.8%</td><td align="left" valign="top" rowspan="1" colspan="1">20.0%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total (all substances)</td><td align="left" valign="top" rowspan="1" colspan="1">19.9%</td><td align="left" valign="top" rowspan="1" colspan="1">17.5%</td></tr></tbody></table><table-wrap-foot id="dar14008-ntgp-0005"><fn id="dar14008-note-0012"><p>
<italic toggle="yes">Note</italic>: Diagnosis includes dependence only.</p></fn></table-wrap-foot></table-wrap><p>Comparing the number of people who met diagnostic criteria and were suitable for treatment, with the number of people who received treatment in Australia provides a gap analysis. Table&#160;<xref rid="dar14008-tbl-0006" ref-type="table">6</xref> shows the number of people who miss out on treatment; between 207,966 and 469,767 people missed out on AOD treatment in Australia for 2022/2023.</p><table-wrap position="float" id="dar14008-tbl-0006" content-type="TABLE" orientation="portrait"><label>TABLE 6</label><caption><p>Estimated number of people missing out on treatment in Australia, 2022/2023.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Drug type</th><th align="left" valign="bottom" rowspan="1" colspan="1">Low prevalence</th><th align="left" valign="bottom" rowspan="1" colspan="1">Mid prevalence</th><th align="left" valign="bottom" rowspan="1" colspan="1">High prevalence</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcohol</td><td align="left" valign="top" rowspan="1" colspan="1">95,967</td><td align="left" valign="top" rowspan="1" colspan="1">153,945</td><td align="left" valign="top" rowspan="1" colspan="1">224,606</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cannabis</td><td align="left" valign="top" rowspan="1" colspan="1">8788</td><td align="left" valign="top" rowspan="1" colspan="1">25,384</td><td align="left" valign="top" rowspan="1" colspan="1">46,054</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Methamphetamine</td><td align="left" valign="top" rowspan="1" colspan="1">30,336</td><td align="left" valign="top" rowspan="1" colspan="1">64,282</td><td align="left" valign="top" rowspan="1" colspan="1">106,808</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Opioids</td><td align="left" valign="top" rowspan="1" colspan="1">72,876</td><td align="left" valign="top" rowspan="1" colspan="1">81,808</td><td align="left" valign="top" rowspan="1" colspan="1">92,299</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="left" valign="top" rowspan="1" colspan="1">207,966</td><td align="left" valign="top" rowspan="1" colspan="1">325,420</td><td align="left" valign="top" rowspan="1" colspan="1">469,767</td></tr></tbody></table></table-wrap><p>Expressed differently, out of the potential treatment population, between 30% and 49% of people received AOD treatment in Australia in 2022/2023 (see Table&#160;<xref rid="dar14008-tbl-0007" ref-type="table">7</xref>).</p><table-wrap position="float" id="dar14008-tbl-0007" content-type="TABLE" orientation="portrait"><label>TABLE 7</label><caption><p>Estimated proportion of the people who did receive treatment, out of the potential treatment population, 2022/2023.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Drug type</th><th align="left" valign="bottom" rowspan="1" colspan="1">Low prevalence</th><th align="left" valign="bottom" rowspan="1" colspan="1">Mid prevalence</th><th align="left" valign="bottom" rowspan="1" colspan="1">High prevalence</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcohol</td><td align="left" valign="top" rowspan="1" colspan="1">39.8%</td><td align="left" valign="top" rowspan="1" colspan="1">29.1%</td><td align="left" valign="top" rowspan="1" colspan="1">22.0%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cannabis</td><td align="left" valign="top" rowspan="1" colspan="1">81.2%</td><td align="left" valign="top" rowspan="1" colspan="1">59.9%</td><td align="left" valign="top" rowspan="1" colspan="1">45.2%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Methamphetamine</td><td align="left" valign="top" rowspan="1" colspan="1">54.4%</td><td align="left" valign="top" rowspan="1" colspan="1">36.0%</td><td align="left" valign="top" rowspan="1" colspan="1">25.3%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Opioids</td><td align="left" valign="top" rowspan="1" colspan="1">45.7%</td><td align="left" valign="top" rowspan="1" colspan="1">42.8%</td><td align="left" valign="top" rowspan="1" colspan="1">39.9%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="left" valign="top" rowspan="1" colspan="1">48.9%</td><td align="left" valign="top" rowspan="1" colspan="1">37.9%</td><td align="left" valign="top" rowspan="1" colspan="1">29.7%</td></tr></tbody></table></table-wrap><p>We did not analyse the number of people missing out on brief interventions, as we do not have adequate data on receipt of brief interventions to undertake this analysis.</p><p>Two previously published estimates (2014 and 2019) of the population proportion who did receive treatment, reveals little change over time, as shown in Table&#160;<xref rid="dar14008-tbl-0008" ref-type="table">8</xref>.</p><table-wrap position="float" id="dar14008-tbl-0008" content-type="TABLE" orientation="portrait"><label>TABLE 8</label><caption><p>Proportion of the people who did receive treatment, out of the potential treatment population, compared with previously published estimates.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Estimate</th><th align="left" valign="bottom" rowspan="1" colspan="1">Our estimates</th><th align="left" valign="bottom" rowspan="1" colspan="1">2019 paper<xref rid="dar14008-note-0013" ref-type="table-fn">
<sup>a</sup>
</xref>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">2014 report<xref rid="dar14008-note-0014" ref-type="table-fn">
<sup>b</sup>
</xref>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Low</td><td align="left" valign="top" rowspan="1" colspan="1">48.9%</td><td align="left" valign="top" rowspan="1" colspan="1">56.4%</td><td align="left" valign="top" rowspan="1" colspan="1">48.5%</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mid</td><td align="left" valign="top" rowspan="1" colspan="1">37.9%</td><td align="left" valign="top" rowspan="1" colspan="1">&#8208;</td><td align="left" valign="top" rowspan="1" colspan="1">&#8208;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">High</td><td align="left" valign="top" rowspan="1" colspan="1">29.7%</td><td align="left" valign="top" rowspan="1" colspan="1">26.8%</td><td align="left" valign="top" rowspan="1" colspan="1">26.4%</td></tr></tbody></table><table-wrap-foot id="dar14008-ntgp-0006"><fn id="dar14008-note-0013"><label>
<sup>a</sup>
</label><p>
<italic toggle="yes">Source</italic>: Ritter et al. [<xref rid="dar14008-bib-0004" ref-type="bibr">4</xref>].</p></fn><fn id="dar14008-note-0014"><label>
<sup>b</sup>
</label><p>
<italic toggle="yes">Source</italic>: Ritter et al. [<xref rid="dar14008-bib-0022" ref-type="bibr">22</xref>].</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion" id="dar14008-sec-0009"><label>4</label><title>DISCUSSION</title><p>The findings from this analysis highlight the continued significant unmet treatment needs of people with SUDs. Less than a third to half of those who should receive treatment accessed treatment in 2022/2023. This is not dissimilar to previous estimates, which ranged from a quarter to half of those in need of treatment receiving treatment [<xref rid="dar14008-bib-0004" ref-type="bibr">4</xref>, <xref rid="dar14008-bib-0022" ref-type="bibr">22</xref>]. In the NSMHWB, 35&#8211;40% of people with a substance dependence disorder reported accessing a mental health service in the past year [<xref rid="dar14008-bib-0014" ref-type="bibr">14</xref>]. While it is not clear whether this was for their AOD use or another mental health issue, it fits within our estimations, providing further confidence in our methods.</p><p>The consistent findings of significant unmet demand for AOD treatment suggests there has been little change in the proportion of people in need of treatment who receive it per year. This aligns with the data published by the Australian Institute of Health and Welfare [<xref rid="dar14008-bib-0025" ref-type="bibr">25</xref>], which shows only a small increase in AOD treatment access per 100,000 people (564 and 568 in 2013/2014 and 2022/2023 respectively). In addition, the recent Australian &#8216;Drug Budgets&#8217; found despite an increase in spending on illicit drug policy (including treatment), spending as a proportion of all government expenditure had decreased between 2009/2010 and 2021/2022 [<xref rid="dar14008-bib-0026" ref-type="bibr">26</xref>].</p><p>While many studies report unmet treatment need rates of up to 80&#8211;90% of the diagnosed population [<xref rid="dar14008-bib-0001" ref-type="bibr">1</xref>, <xref rid="dar14008-bib-0009" ref-type="bibr">9</xref>, <xref rid="dar14008-bib-0011" ref-type="bibr">11</xref>, <xref rid="dar14008-bib-0012" ref-type="bibr">12</xref>], this approach assumes that everyone who meets diagnostic criteria for SUD should receive treatment. In our work, we reduce the potential in&#8208;need population substantially because we take into account both untreated remission and recognise that some people have no desire to receive treatment. This produces a much more realistic &#8216;treatment gap&#8217;. At the same time it is subject to greater uncertainty. However, other methods for assessing the size of treatment gap, for example the use of wait list data, or surveys of key populations who miss out on treatment can bias results. Assuming that only 40% of all people with an alcohol or cannabis use disorder are likely to seek and benefit from treatment shows how conservative the analyses are&#8212;the treatment gap reported here is likely to be the minimum gap.</p><p>The population who meet diagnostic criteria but are not included in the treatment estimates are likely to still benefit from some form of intervention. As others have highlighted [<xref rid="dar14008-bib-0040" ref-type="bibr">40</xref>], a less intensive intervention, possibly provided in a primary care setting may be adequate. Our work provides an estimate of the number of people who could receive a brief intervention. Another population to be considered are those people who do not meet diagnostic criteria but are consuming in &#8216;risky&#8217; quantities or experiencing harms. This is sometimes called the &#8216;at&#8208;risk&#8217; population. Some of these people may seek or perceive a need for treatment, and would likely benefit from some form of intervention. Investing in interventions at the earlier stages of someone's substance use can prevent the need for more intensive interventions later on. Similarly, investing in prevention interventions, such as education and social supports, as well as pricing and other regulatory policies for legal drugs such as alcohol [<xref rid="dar14008-bib-0041" ref-type="bibr">41</xref>], would reduce the need for AOD treatment in the long&#8208;term.</p><sec id="dar14008-sec-0010"><label>4.1</label><title>
Limitations
</title><p>There are several key assumptions made in deriving these estimates. One assumption is the proportion of the population meeting diagnostic criteria who intend to seek treatment, and do not resolve their AOD problems without intervention. Estimating this proportion of the diagnosed population (40&#8211;90% depending on the drug type) is subjective. While based on the best available evidence and expert advice, there is considerable uncertainty in these parameters which can impact the resulting estimates.</p><p>In addition to the proportion of the diagnosed population who we assume should receive treatment, there have been many changes made to the diagnostic criteria over time [<xref rid="dar14008-bib-0021" ref-type="bibr">21</xref>]. The number of people who meet diagnostic criteria over time will therefore inevitably change, even if the number of people experiencing difficulties or harms remains stable.</p><p>We also have considerable uncertainty in the number of people who do receive treatment. While we have comprehensive data from the two main databases in Australia, the number of people accessing treatment outside these two databases is less clear. We employed a multiplier from an earlier analysis, however we do not know whether the proportion of treatment delivered in these settings has changed since that analysis.</p><p>Our analysis is focused on Australia nationally. We know that some geographic regions and populations have higher treatment need than others. These findings are therefore only applicable to Australia as a whole, but cannot be used to determine treatment needs in a particular region/area. In addition, this work does not provide estimation of treatment gaps for specific service types (e.g., withdrawal or residential rehabilitation). It also does not include one substance associated with high health costs, tobacco [<xref rid="dar14008-bib-0042" ref-type="bibr">42</xref>]. Analysis of unmet demand for tobacco/nicotine dependence treatment would be a valuable area for future research.</p></sec><sec id="dar14008-sec-0011"><label>4.2</label><title>
Implications
</title><p>AOD treatment is significantly underfunded and under&#8208;resourced. In 2022/2023, less than half of the people suitable for AOD treatment received it. Understanding the population in need, and those not receiving treatment can help to better plan for treatment services. In this paper we have provided an updated analysis of the number and proportion of people &#8216;missing out&#8217; on AOD treatment, which may be used to better plan for service needs.</p></sec></sec><sec id="dar14008-sec-0012"><title>AUTHOR CONTRIBUTIONS</title><p>Each author certifies that their contribution to this work meets the standards of the International Committee of Medical Journal Editors.</p></sec><sec sec-type="COI-statement" id="dar14008-sec-0014"><title>CONFLICT OF INTEREST STATEMENT</title><p>None.</p></sec></body><back><ack id="dar14008-sec-0013"><title>ACKNOWLEDGEMENTS</title><p>Alison Ritter receives a National Health and Medical Research Council Investigator Fellowship, GNT2016695. This work has been informed by projects updating the Drug and Alcohol Services Planning Model. The authors thank the Queensland Department of Health and the Victorian Department of Health for their funding of these projects, as well as the many Expert Reference Group members who guided the development of the Drug and Alcohol Services Planning Model. Open access publishing facilitated by University of New South Wales, as part of the Wiley &#8208; University of New South Wales agreement via the Council of Australian University Librarians.</p></ack><fn-group id="dar14008-ntgp-0007"><title>Endnote</title><fn id="dar14008-note-0015"><label>
<sup>1</sup>
</label><p>We used a select number of sources from the systematic review which involved a sample of people who previously had a diagnosis of an alcohol use disorder but no longer met criteria, were abstinent, or used in moderation over the past year: Dawson et al. (1996); Dawson et al. (2005); Dawson et al. (2006); Tuithof et al. (2016). See&#160;Table <xref rid="dar14008-tbl-0001" ref-type="table">1</xref> of [19].</p></fn></fn-group><sec sec-type="data-availability" id="dar14008-sec-0016"><title>DATA AVAILABILITY STATEMENT</title><p>These data were derived from the following resources available in the public domain: GBD Results 2021, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://vizhub.healthdata.org/gbd-results/" ext-link-type="uri" specific-use="software is-supplemented-by">https://vizhub.healthdata.org/gbd-results/</ext-link>; Alcohol and other drug treatment services in Australia, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/alcohol-other-drug-treatment-services-australia/data" ext-link-type="uri" specific-use="software is-supplemented-by">https://www.aihw.gov.au/reports/alcohol&#8208;other&#8208;drug&#8208;treatment&#8208;services/alcohol&#8208;other&#8208;drug&#8208;treatment&#8208;services&#8208;australia/data</ext-link>; National Opioid Pharmacotherapy Statistics Annual Data, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.aihw.gov.au/reports/alcohol-other-drug-treatment-services/national-opioid-pharmacotherapy-statistics/contents/about" ext-link-type="uri" specific-use="software is-supplemented-by">https://www.aihw.gov.au/reports/alcohol&#8208;other&#8208;drug&#8208;treatment&#8208;services/national&#8208;opioid&#8208;pharmacotherapy&#8208;statistics/contents/about</ext-link>.</p></sec><ref-list id="dar14008-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="dar14008-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="dar14008-cit-0001"><string-name name-style="western"><surname>Hayes</surname><given-names>BB</given-names></string-name>. <article-title>Annual use and perceived need for mental health and substance treatment among people in remission from substance use disorders in the United States</article-title>. <source>Drug Alcohol Depend</source>. <year>2023</year>;<volume>249</volume>:<fpage>1</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2023.110820</pub-id><pub-id pub-id-type="pmid">37329728</pub-id></mixed-citation></ref><ref id="dar14008-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="dar14008-cit-0002"><string-name name-style="western"><surname>Chiou</surname><given-names>J&#8208;Y</given-names></string-name>. <article-title>Met and unmet need for substance abuse treatment among American adults with a self&#8208;reported dual diagnosis of substance abuse and mental diseaseDP&#8212;2003</article-title>. <source>Diss Abstr Int</source>. <year>2003</year>;<volume>64</volume>(<issue>1&#8208;B</issue>):<fpage>132</fpage>.</mixed-citation></ref><ref id="dar14008-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="dar14008-cit-0003"><string-name name-style="western"><surname>Shepard</surname><given-names>DS</given-names></string-name>, <string-name name-style="western"><surname>Strickler</surname><given-names>GK</given-names></string-name>, <string-name name-style="western"><surname>McAuliffe</surname><given-names>WE</given-names></string-name>, <string-name name-style="western"><surname>Beaston&#8208;Blaakman</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Rahman</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>TE</given-names></string-name>. <article-title>Unmet need for substance abuse treatment of adults in Massachusetts</article-title>. <source>Admin Pol Ment Health</source>. <year>2005</year>;<volume>32</volume>:<fpage>403</fpage>&#8211;<lpage>426</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10488-004-1667-y</pub-id><pub-id pub-id-type="pmid">15844857</pub-id></mixed-citation></ref><ref id="dar14008-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="dar14008-cit-0004"><string-name name-style="western"><surname>Ritter</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Chalmers</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Gomez</surname><given-names>M</given-names></string-name>. <article-title>Measuring unmet demand for alcohol and other drug treatment: the application of an Australian population&#8208;based planning model</article-title>. <source>J Stud Alcohol Drugs Suppl</source>. <year>2019</year>;<volume>Sup 18:</volume>(<issue>Suppl 18</issue>):<fpage>42</fpage>&#8211;<lpage>50</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.15288/jsads.2019.s18.42</pub-id><pub-id pub-id-type="pmcid">PMC6377016</pub-id><pub-id pub-id-type="pmid">30681948</pub-id></mixed-citation></ref><ref id="dar14008-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="dar14008-cit-0005"><string-name name-style="western"><surname>Teesson</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hall</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Slade</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Mills</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Grove</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Mewton</surname><given-names>L</given-names></string-name>, et al. <article-title>Prevalence and correlates of DSM&#8208;IV alcohol abuse and dependence in Australia: findings of the 2007 National Survey of mental health and wellbeing</article-title>. <source>Addiction</source>. <year>2010</year>;<volume>105</volume>:<fpage>2085</fpage>&#8211;<lpage>2094</lpage>.<pub-id pub-id-type="pmid">20707771</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1360-0443.2010.03096.x</pub-id></mixed-citation></ref><ref id="dar14008-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="dar14008-cit-0006"><string-name name-style="western"><surname>Borges</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Medina&#8208;Mora</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Orozco</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Fleiz</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Villatoro</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Rojas</surname><given-names>E</given-names></string-name>, et al. <article-title>Unmet needs for treatment of alcohol and drug use in four cities in Mexico</article-title>. <source>Salud Ment</source>. <year>2009</year>;<volume>32</volume>:<fpage>327</fpage>&#8211;<lpage>333</lpage>.</mixed-citation></ref><ref id="dar14008-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="dar14008-cit-0007"><string-name name-style="western"><surname>Edlund</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Booth</surname><given-names>BM</given-names></string-name>, <string-name name-style="western"><surname>Han</surname><given-names>X</given-names></string-name>. <article-title>Who seeks care where? Utilization of mental health and substance use disorder treatment in two national samples of individuals with alcohol use disorders</article-title>. <source>J Stud Alcohol Drugs</source>. <year>2012</year>;<volume>73</volume>:<fpage>635</fpage>&#8211;<lpage>646</lpage>.<pub-id pub-id-type="pmid">22630802</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15288/jsad.2012.73.635</pub-id><pub-id pub-id-type="pmcid">PMC3364329</pub-id></mixed-citation></ref><ref id="dar14008-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="dar14008-cit-0008"><string-name name-style="western"><surname>Subramaniam</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Abdin</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Vaingankar</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Shafie</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Chua</surname><given-names>HC</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>WM</given-names></string-name>, et al. <article-title>Minding the treatment gap: results of the Singapore mental health study</article-title>. <source>Soc Psychiatry Psychiatr Epidemiol</source>. <year>2020</year>;<volume>55</volume>:<fpage>1415</fpage>&#8211;<lpage>1424</lpage>.<pub-id pub-id-type="pmid">31317246</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00127-019-01748-0</pub-id><pub-id pub-id-type="pmcid">PMC7578124</pub-id></mixed-citation></ref><ref id="dar14008-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="dar14008-cit-0009"><string-name name-style="western"><surname>Han</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Compton</surname><given-names>WM</given-names></string-name>, <string-name name-style="western"><surname>Blanco</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Colpe</surname><given-names>LJ</given-names></string-name>. <article-title>Prevalence, treatment, and unmet treatment needs of US adults with mental health and substance use disorders</article-title>. <source>Health Aff</source>. <year>2017</year>;<volume>36</volume>:<fpage>1739</fpage>&#8211;<lpage>1747</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1377/hlthaff.2017.0584</pub-id><pub-id pub-id-type="pmid">28971918</pub-id></mixed-citation></ref><ref id="dar14008-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="dar14008-cit-0010"><string-name name-style="western"><surname>Sahker</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Pro</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Poudyal</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Furukawa</surname><given-names>TA</given-names></string-name>. <article-title>Evaluating the substance use disorder treatment gap in the United States, 2016&#8208;2019: a population health observational study</article-title>. <source>Am J Addict</source>. <year>2024</year>;<volume>33</volume>:<fpage>36</fpage>&#8211;<lpage>47</lpage>.<pub-id pub-id-type="pmid">37583093</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ajad.13465</pub-id></mixed-citation></ref><ref id="dar14008-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="dar14008-cit-0011"><string-name name-style="western"><surname>Fernandez</surname><given-names>LG</given-names></string-name>, <string-name name-style="western"><surname>Yoon</surname><given-names>GH</given-names></string-name>, <string-name name-style="western"><surname>Firima</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Gupta</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Sematle</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Khomolishoele</surname><given-names>M</given-names></string-name>, et al. <article-title>Prevalence of mental health and substance use problems and awareness of need for services in Lesotho: results from a population&#8208;based survey</article-title>. <source>Int J Ment Heal Addict</source>. <year>2024</year>.</mixed-citation></ref><ref id="dar14008-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="dar14008-cit-0012"><string-name name-style="western"><surname>M&#246;ckl</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lindemann</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Manthey</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Schulte</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Reimer</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Pogarell</surname><given-names>O</given-names></string-name>, et al. <article-title>Estimating the prevalence of alcohol&#8208;related disorders and treatment utilization in Bremen 2016/2017 through routine data linkage</article-title>. <source>Front Psychiatry</source>. <year>2023</year>;<volume>14</volume>:<elocation-id>1002526</elocation-id>.<pub-id pub-id-type="pmid">36778636</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fpsyt.2023.1002526</pub-id><pub-id pub-id-type="pmcid">PMC9909027</pub-id></mixed-citation></ref><ref id="dar14008-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="dar14008-cit-0013"><string-name name-style="western"><surname>Mekonen</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Chan</surname><given-names>GC</given-names></string-name>, <string-name name-style="western"><surname>Connor</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hall</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Hides</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Leung</surname><given-names>J</given-names></string-name>. <article-title>Treatment rates for alcohol use disorders: a systematic review and meta&#8208;analysis</article-title>. <source>Addiction</source>. <year>2021</year>;<volume>116</volume>:<fpage>2617</fpage>&#8211;<lpage>2634</lpage>.<pub-id pub-id-type="pmid">33245581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/add.15357</pub-id></mixed-citation></ref><ref id="dar14008-bib-0014"><label>14</label><mixed-citation publication-type="miscellaneous" id="dar14008-cit-0014"><collab collab-type="authors">Australian Bureau of Statistics</collab>
. <article-title>National Study of Mental Health and Wellbeing. 2020&#8211;22</article-title>.</mixed-citation></ref><ref id="dar14008-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="dar14008-cit-0015"><string-name name-style="western"><surname>Feingold</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Fox</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Rehm</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lev&#8208;Ran</surname><given-names>S</given-names></string-name>. <article-title>Natural outcome of cannabis use disorder: a 3&#8208;year longitudinal follow&#8208;up</article-title>. <source>Addiction</source>. <year>2015</year>;<volume>110</volume>:<fpage>1963</fpage>&#8211;<lpage>1974</lpage>.<pub-id pub-id-type="pmid">26212076</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/add.13071</pub-id></mixed-citation></ref><ref id="dar14008-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="dar14008-cit-0016"><string-name name-style="western"><surname>Quinn</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Stoov&#233;</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Dietze</surname><given-names>P</given-names></string-name>. <article-title>One&#8208;year changes in methamphetamine use, dependence and remission in a community&#8208;recruited cohort</article-title>. <source>J Subst Abus</source>. <year>2016</year>;<volume>21</volume>:<fpage>279</fpage>&#8211;<lpage>286</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ADM.0000000000000469</pub-id><pub-id pub-id-type="pmid">30379780</pub-id></mixed-citation></ref><ref id="dar14008-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="dar14008-cit-0017"><string-name name-style="western"><surname>Stea</surname><given-names>JN</given-names></string-name>, <string-name name-style="western"><surname>Yakovenko</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Hodgins</surname><given-names>DC</given-names></string-name>. <article-title>Recovery from cannabis use disorders: abstinence versus moderation and treatment&#8208;assisted recovery versus natural recovery</article-title>. <source>Psychol Addict Behav</source>. <year>2015</year>;<volume>29</volume>:<fpage>522</fpage>&#8211;<lpage>531</lpage>.<pub-id pub-id-type="pmid">26168224</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1037/adb0000097</pub-id></mixed-citation></ref><ref id="dar14008-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="dar14008-cit-0018"><string-name name-style="western"><surname>Mellor</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Lancaster</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ritter</surname><given-names>A</given-names></string-name>. <article-title>Examining untreated and treated alcohol problem resolution in an Australian online survey sample</article-title>. <source>Drug Alcohol Rev</source>. <year>2021</year>;<volume>40</volume>:<fpage>1037</fpage>&#8211;<lpage>1046</lpage>.<pub-id pub-id-type="pmid">33647176</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/dar.13257</pub-id></mixed-citation></ref><ref id="dar14008-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="dar14008-cit-0019"><string-name name-style="western"><surname>Mellor</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Lancaster</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ritter</surname><given-names>A</given-names></string-name>. <article-title>Systematic review of untreated remission from alcohol problems: estimation lies in the eye of the beholder</article-title>. <source>J Subst Abus Treat</source>. <year>2019</year>;<volume>102</volume>:<fpage>60</fpage>&#8211;<lpage>72</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jsat.2019.04.004</pub-id><pub-id pub-id-type="pmid">31202290</pub-id></mixed-citation></ref><ref id="dar14008-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="dar14008-cit-0020"><string-name name-style="western"><surname>Chalmers</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ritter</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Berends</surname><given-names>L</given-names></string-name>. <article-title>Estimating met demand for alcohol and other drug treatment in Australia</article-title>. <source>Addiction</source>. <year>2016</year>;<volume>111</volume>:<fpage>2041</fpage>&#8211;<lpage>2049</lpage>.<pub-id pub-id-type="pmid">27247161</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/add.13473</pub-id></mixed-citation></ref><ref id="dar14008-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="dar14008-cit-0021"><string-name name-style="western"><surname>Ritter</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Mellor</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Chalmers</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Sunderland</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lancaster</surname><given-names>K</given-names></string-name>. <article-title>Key considerations in planning for substance use treatment: estimating treatment need and demand</article-title>. <source>J Stud Alcohol Drugs Suppl</source>. <year>2019</year>;<volume>Sup 18</volume>:<fpage>22</fpage>&#8211;<lpage>30</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.15288/jsads.2019.s18.22</pub-id><pub-id pub-id-type="pmcid">PMC6377022</pub-id><pub-id pub-id-type="pmid">30681945</pub-id></mixed-citation></ref><ref id="dar14008-bib-0022"><label>22</label><mixed-citation publication-type="miscellaneous" id="dar14008-cit-0022"><string-name name-style="western"><surname>Ritter</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Berends</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Chalmers</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hull</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Lancaster</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Gomez</surname><given-names>M</given-names></string-name>. <article-title>New horizons: the review of alcohol and other drug treatment services in Australia. Drug Policy Modelling Program, National Drug and Alcohol Research Centre</article-title>. <year>2014</year>.</mixed-citation></ref><ref id="dar14008-bib-0023"><label>23</label><mixed-citation publication-type="miscellaneous" id="dar14008-cit-0023"><collab collab-type="authors">Australian Institute of Health &amp; Welfare</collab>
. <article-title>National Drug Strategy Household Survey 2022/23</article-title>. <year>2024</year>.</mixed-citation></ref><ref id="dar14008-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="dar14008-cit-0024"><string-name name-style="western"><surname>Man</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Sisson</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>McKetin</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Chrzanowska</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Bruno</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Dietze</surname><given-names>PM</given-names></string-name>, et al. <article-title>Trends in methamphetamine use, markets and harms in Australia, 2003&#8211;2019</article-title>. <source>Drug Alcohol Rev</source>. <year>2022</year>;<volume>41</volume>:<fpage>1041</fpage>&#8211;<lpage>1052</lpage>.<pub-id pub-id-type="pmid">35604870</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/dar.13468</pub-id></mixed-citation></ref><ref id="dar14008-bib-0025"><label>25</label><mixed-citation publication-type="book" id="dar14008-cit-0025"><collab collab-type="authors">Australian Institute of Health &amp; Welfare</collab>
. <source>Alcohol and other drug treatment services in Australia: annual report 2022&#8211;23</source>. <publisher-loc>Canberra</publisher-loc>: <publisher-name>AIHW</publisher-name>; <year>2024</year>.</mixed-citation></ref><ref id="dar14008-bib-0026"><label>26</label><mixed-citation publication-type="miscellaneous" id="dar14008-cit-0026"><string-name name-style="western"><surname>Ritter</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Grealy</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kelaita</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Kowalski</surname><given-names>M</given-names></string-name>. <article-title>The Australian &#8216;drug budget&#8217;: government drug policy expenditure 2021/22</article-title>. <year>2024</year>.</mixed-citation></ref><ref id="dar14008-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="dar14008-cit-0027"><string-name name-style="western"><surname>Madras</surname><given-names>BK</given-names></string-name>, <string-name name-style="western"><surname>Compton</surname><given-names>WM</given-names></string-name>, <string-name name-style="western"><surname>Avula</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Stegbauer</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Stein</surname><given-names>JB</given-names></string-name>, <string-name name-style="western"><surname>Clark</surname><given-names>HW</given-names></string-name>. <article-title>Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later</article-title>. <source>Drug Alcohol Depend</source>. <year>2009</year>;<volume>99</volume>:<fpage>280</fpage>&#8211;<lpage>295</lpage>.<pub-id pub-id-type="pmid">18929451</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2008.08.003</pub-id><pub-id pub-id-type="pmcid">PMC2760304</pub-id></mixed-citation></ref><ref id="dar14008-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="dar14008-cit-0028"><string-name name-style="western"><surname>O'Donnell</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Newbury&#8208;Birch</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Schulte</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Schmidt</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Reimer</surname><given-names>J</given-names></string-name>, et al. <article-title>The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews</article-title>. <source>Alcohol Alcohol</source>. <year>2014</year>;<volume>49</volume>:<fpage>66</fpage>&#8211;<lpage>78</lpage>.<pub-id pub-id-type="pmid">24232177</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/alcalc/agt170</pub-id><pub-id pub-id-type="pmcid">PMC3865817</pub-id></mixed-citation></ref><ref id="dar14008-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="dar14008-cit-0029"><string-name name-style="western"><surname>Bertholet</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Daeppen</surname><given-names>J&#8208;B</given-names></string-name>, <string-name name-style="western"><surname>Wietlisbach</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Fleming</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Burnand</surname><given-names>B</given-names></string-name>. <article-title>Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta&#8208;analysis</article-title>. <source>Arch Intern Med</source>. <year>2005</year>;<volume>165</volume>:<fpage>986</fpage>&#8211;<lpage>995</lpage>.<pub-id pub-id-type="pmid">15883236</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archinte.165.9.986</pub-id></mixed-citation></ref><ref id="dar14008-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="dar14008-cit-0030"><string-name name-style="western"><surname>Babor</surname><given-names>TF</given-names></string-name>, <string-name name-style="western"><surname>McRee</surname><given-names>BG</given-names></string-name>, <string-name name-style="western"><surname>Kassebaum</surname><given-names>PA</given-names></string-name>, <string-name name-style="western"><surname>Grimaldi</surname><given-names>PL</given-names></string-name>, <string-name name-style="western"><surname>Ahmed</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Bray</surname><given-names>J</given-names></string-name>. <article-title>Screening, brief intervention, and referral to treatment (SBIRT): toward a public health approach to the management of substance abuse</article-title>. <source>Subst Abus</source>. <year>2027</year>;<volume>28</volume>:<fpage>7</fpage>&#8211;<lpage>30</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1300/J465v28n03_03</pub-id><pub-id pub-id-type="pmid">18077300</pub-id></mixed-citation></ref><ref id="dar14008-bib-0031"><label>31</label><mixed-citation publication-type="miscellaneous" id="dar14008-cit-0031"><collab collab-type="authors">Institute for Health Metrics and Evaluation (IHME)</collab>
. <article-title>Global Burden of Disease results Seattle, WA: Institute for Health Metrics and Evaluation, University of Washington; 2021</article-title>. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://vizhub.healthdata.org/gbd-results/" ext-link-type="uri">https://vizhub.healthdata.org/gbd-results/</ext-link></mixed-citation></ref><ref id="dar14008-bib-0032"><label>32</label><mixed-citation publication-type="miscellaneous" id="dar14008-cit-0032"><collab collab-type="authors">Australian Bureau of Statistics</collab>
. <article-title>National, state and territory population: June 2023</article-title>. <year>2023</year>. Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.abs.gov.au/statistics/people/population/national-state-and-territory-population/jun-2023" ext-link-type="uri">https://www.abs.gov.au/statistics/people/population/national&#8208;state&#8208;and&#8208;territory&#8208;population/jun&#8208;2023</ext-link></mixed-citation></ref><ref id="dar14008-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="dar14008-cit-0033"><string-name name-style="western"><surname>Downing</surname><given-names>BC</given-names></string-name>, <string-name name-style="western"><surname>Hickman</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Jones</surname><given-names>NR</given-names></string-name>, <string-name name-style="western"><surname>Larney</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sweeting</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>Y</given-names></string-name>, et al. <article-title>Prevalence of opioid dependence in New South Wales, Australia, 2014&#8211;16: indirect estimation from multiple data sources using a Bayesian approach</article-title>. <source>Addiction</source>. <year>2023</year>;<volume>118</volume>:<fpage>1994</fpage>&#8211;<lpage>2006</lpage>.<pub-id pub-id-type="pmid">37292044</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/add.16268</pub-id></mixed-citation></ref><ref id="dar14008-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="dar14008-cit-0034"><string-name name-style="western"><surname>van der Pol</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Liebregts</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>de Graaf</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Korf</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>van den Brink</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>van Laar</surname><given-names>M</given-names></string-name>. <article-title>Three&#8208;year course of cannabis dependence and prediction of persistence</article-title>. <source>Eur Addict Res</source>. <year>2015</year>;<volume>21</volume>:<fpage>279</fpage>&#8211;<lpage>290</lpage>.<pub-id pub-id-type="pmid">26044258</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000377625</pub-id></mixed-citation></ref><ref id="dar14008-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="dar14008-cit-0035"><string-name name-style="western"><surname>Kelly</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Bergman</surname><given-names>BG</given-names></string-name>, <string-name name-style="western"><surname>Hoeppner</surname><given-names>BB</given-names></string-name>, <string-name name-style="western"><surname>Vilsaint</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>White</surname><given-names>WL</given-names></string-name>. <article-title>Prevalence and pathways of recovery from drug and alcohol problems in the United States population: implications for practice, research, and policy</article-title>. <source>Drug Alcohol Depend</source>. <year>2017</year>;<volume>181</volume>:<fpage>162</fpage>&#8211;<lpage>169</lpage>.<pub-id pub-id-type="pmid">29055821</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2017.09.028</pub-id><pub-id pub-id-type="pmcid">PMC6076174</pub-id></mixed-citation></ref><ref id="dar14008-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="dar14008-cit-0036"><string-name name-style="western"><surname>Lanyon</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Nambiar</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Higgs</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Dietze</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Quinn</surname><given-names>B</given-names></string-name>. <article-title>Five&#8208;year changes in methamphetamine use, dependence, and remission in a community&#8208;recruited cohort</article-title>. <source>J Addict Med</source>. <year>2019</year>;<volume>13</volume>:<fpage>159</fpage>&#8211;<lpage>165</lpage>.<pub-id pub-id-type="pmid">30379780</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ADM.0000000000000469</pub-id></mixed-citation></ref><ref id="dar14008-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="dar14008-cit-0037"><string-name name-style="western"><surname>Fleury</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Djouini</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hu&#7923;nh</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Tremblay</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ferland</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>M&#233;nard</surname><given-names>JM</given-names></string-name>, et al. <article-title>Remission from substance use disorders: a systematic review and meta&#8208;analysis</article-title>. <source>Drug Alcohol Depend</source>. <year>2016</year>;<volume>168</volume>:<fpage>293</fpage>&#8211;<lpage>306</lpage>.<pub-id pub-id-type="pmid">27614380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2016.08.625</pub-id></mixed-citation></ref><ref id="dar14008-bib-0038"><label>38</label><mixed-citation publication-type="miscellaneous" id="dar14008-cit-0038"><string-name name-style="western"><surname>Stephens</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Clifford</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Mellor</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>van de Ven</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ritter</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>JA</given-names></string-name>, et al. <article-title>Demand study for alcohol treatment services in the Northern Territory</article-title>. <year>2019</year>.</mixed-citation></ref><ref id="dar14008-bib-0039"><label>39</label><mixed-citation publication-type="miscellaneous" id="dar14008-cit-0039"><string-name name-style="western"><surname>Mellor</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Ritter</surname><given-names>A</given-names></string-name>. <article-title>Treatment demand modelling for alcohol and other drug treatment in the ACT: ATODA</article-title>. <year>2021</year>.</mixed-citation></ref><ref id="dar14008-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="dar14008-cit-0040"><string-name name-style="western"><surname>Tuithof</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>ten Have</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>van den Brink</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Vollebergh</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>de Graaf</surname><given-names>R</given-names></string-name>. <article-title>Treatment seeking for alcohol use disorders: treatment gap or adequate self&#8208;selection?</article-title><source>Eur Addict Res</source>. <year>2016</year>;<volume>22</volume>:<fpage>277</fpage>&#8211;<lpage>285</lpage>.<pub-id pub-id-type="pmid">27287873</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000446822</pub-id></mixed-citation></ref><ref id="dar14008-bib-0041"><label>41</label><mixed-citation publication-type="miscellaneous" id="dar14008-cit-0041"><collab collab-type="authors">World Health Organization</collab>
. <article-title>&#8216;Best buys&#8217; and other recommended interventions for the prevention and control of noncommunicable diseases</article-title>. <year>2017</year>.</mixed-citation></ref><ref id="dar14008-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="dar14008-cit-0042"><string-name name-style="western"><surname>Makate</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Whetton</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Tait</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Dey</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Scollo</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Banks</surname><given-names>E</given-names></string-name>, et al. <article-title>Tobacco cost of illness studies: a systematic review</article-title>. <source>Nicotine Tob Res</source>. <year>2020</year>;<volume>22</volume>:<fpage>458</fpage>&#8211;<lpage>465</lpage>.<pub-id pub-id-type="pmid">30874290</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ntr/ntz038</pub-id></mixed-citation></ref></ref-list><app-group><app id="dar14008-app-0001" content-type="APPENDIX"><sec id="dar14008-sec-0018"><title>PREVALENCE RATES FOR THE FOUR DRUG TYPES USED IN THE ANALYSIS</title><table-wrap position="anchor" id="dar14008-tbl-0009" content-type="TABLE" orientation="portrait"><label>TABLE A1</label><caption><p>Prevalence rates used in the analysis, sourced from the Global Burden of Disease (2021) and Downing et al. (2023).</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th rowspan="2" align="left" valign="bottom" colspan="1"/><th colspan="15" align="left" valign="bottom" rowspan="1">Age group, years</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">10&#8211;14 (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">15&#8211;19 (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">20&#8211;24 (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">25&#8211;29 (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">30&#8211;34 (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">35&#8211;39 (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">40&#8211;44 (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">45&#8211;49 (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">50&#8211;54 (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">55&#8211;59 (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">60&#8211;64 (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">65&#8211;69 (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">70&#8211;74 (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">75&#8211;79 (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">80+ (%)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Low</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Alcohol<xref rid="dar14008-note-0016" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">0.07</td><td align="left" valign="top" rowspan="1" colspan="1">0.80</td><td align="left" valign="top" rowspan="1" colspan="1">1.95</td><td align="left" valign="top" rowspan="1" colspan="1">2.53</td><td align="left" valign="top" rowspan="1" colspan="1">2.48</td><td align="left" valign="top" rowspan="1" colspan="1">2.70</td><td align="left" valign="top" rowspan="1" colspan="1">2.53</td><td align="left" valign="top" rowspan="1" colspan="1">2.25</td><td align="left" valign="top" rowspan="1" colspan="1">1.73</td><td align="left" valign="top" rowspan="1" colspan="1">1.59</td><td align="left" valign="top" rowspan="1" colspan="1">1.30</td><td align="left" valign="top" rowspan="1" colspan="1">1.17</td><td align="left" valign="top" rowspan="1" colspan="1">0.96</td><td align="left" valign="top" rowspan="1" colspan="1">0.83</td><td align="left" valign="top" rowspan="1" colspan="1">0.98</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cannabis<xref rid="dar14008-note-0016" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">0.11</td><td align="left" valign="top" rowspan="1" colspan="1">1.58</td><td align="left" valign="top" rowspan="1" colspan="1">1.84</td><td align="left" valign="top" rowspan="1" colspan="1">1.06</td><td align="left" valign="top" rowspan="1" colspan="1">0.63</td><td align="left" valign="top" rowspan="1" colspan="1">0.43</td><td align="left" valign="top" rowspan="1" colspan="1">0.31</td><td align="left" valign="top" rowspan="1" colspan="1">0.23</td><td align="left" valign="top" rowspan="1" colspan="1">0.17</td><td align="left" valign="top" rowspan="1" colspan="1">0.12</td><td align="left" valign="top" rowspan="1" colspan="1">0.08</td><td align="left" valign="top" rowspan="1" colspan="1">0.05</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td><td align="left" valign="top" rowspan="1" colspan="1">0.02</td><td align="left" valign="top" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Amphet<xref rid="dar14008-note-0016" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">0.27</td><td align="left" valign="top" rowspan="1" colspan="1">1.26</td><td align="left" valign="top" rowspan="1" colspan="1">1.40</td><td align="left" valign="top" rowspan="1" colspan="1">0.81</td><td align="left" valign="top" rowspan="1" colspan="1">0.46</td><td align="left" valign="top" rowspan="1" colspan="1">0.28</td><td align="left" valign="top" rowspan="1" colspan="1">0.15</td><td align="left" valign="top" rowspan="1" colspan="1">0.07</td><td align="left" valign="top" rowspan="1" colspan="1">0.04</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td><td align="left" valign="top" rowspan="1" colspan="1">0.02</td><td align="left" valign="top" rowspan="1" colspan="1">0.02</td><td align="left" valign="top" rowspan="1" colspan="1">0.01</td><td align="left" valign="top" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Opioids<xref rid="dar14008-note-0017" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">0.89</td><td align="left" valign="top" rowspan="1" colspan="1">0.89</td><td align="left" valign="top" rowspan="1" colspan="1">0.89</td><td align="left" valign="top" rowspan="1" colspan="1">0.89</td><td align="left" valign="top" rowspan="1" colspan="1">0.89</td><td align="left" valign="top" rowspan="1" colspan="1">0.89</td><td align="left" valign="top" rowspan="1" colspan="1">0.82</td><td align="left" valign="top" rowspan="1" colspan="1">0.82</td><td align="left" valign="top" rowspan="1" colspan="1">0.82</td><td align="left" valign="top" rowspan="1" colspan="1">0.82</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Main</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Alcohol<xref rid="dar14008-note-0016" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">0.13</td><td align="left" valign="top" rowspan="1" colspan="1">1.23</td><td align="left" valign="top" rowspan="1" colspan="1">3.05</td><td align="left" valign="top" rowspan="1" colspan="1">3.51</td><td align="left" valign="top" rowspan="1" colspan="1">3.50</td><td align="left" valign="top" rowspan="1" colspan="1">3.49</td><td align="left" valign="top" rowspan="1" colspan="1">3.34</td><td align="left" valign="top" rowspan="1" colspan="1">2.85</td><td align="left" valign="top" rowspan="1" colspan="1">2.37</td><td align="left" valign="top" rowspan="1" colspan="1">2.04</td><td align="left" valign="top" rowspan="1" colspan="1">1.75</td><td align="left" valign="top" rowspan="1" colspan="1">1.50</td><td align="left" valign="top" rowspan="1" colspan="1">1.30</td><td align="left" valign="top" rowspan="1" colspan="1">1.21</td><td align="left" valign="top" rowspan="1" colspan="1">1.25</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cannabis<xref rid="dar14008-note-0016" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">0.19</td><td align="left" valign="top" rowspan="1" colspan="1">2.13</td><td align="left" valign="top" rowspan="1" colspan="1">2.33</td><td align="left" valign="top" rowspan="1" colspan="1">1.41</td><td align="left" valign="top" rowspan="1" colspan="1">0.88</td><td align="left" valign="top" rowspan="1" colspan="1">0.61</td><td align="left" valign="top" rowspan="1" colspan="1">0.45</td><td align="left" valign="top" rowspan="1" colspan="1">0.34</td><td align="left" valign="top" rowspan="1" colspan="1">0.25</td><td align="left" valign="top" rowspan="1" colspan="1">0.17</td><td align="left" valign="top" rowspan="1" colspan="1">0.11</td><td align="left" valign="top" rowspan="1" colspan="1">0.07</td><td align="left" valign="top" rowspan="1" colspan="1">0.05</td><td align="left" valign="top" rowspan="1" colspan="1">0.04</td><td align="left" valign="top" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Amphet<xref rid="dar14008-note-0016" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">0.43</td><td align="left" valign="top" rowspan="1" colspan="1">1.93</td><td align="left" valign="top" rowspan="1" colspan="1">2.03</td><td align="left" valign="top" rowspan="1" colspan="1">1.20</td><td align="left" valign="top" rowspan="1" colspan="1">0.72</td><td align="left" valign="top" rowspan="1" colspan="1">0.43</td><td align="left" valign="top" rowspan="1" colspan="1">0.23</td><td align="left" valign="top" rowspan="1" colspan="1">0.12</td><td align="left" valign="top" rowspan="1" colspan="1">0.07</td><td align="left" valign="top" rowspan="1" colspan="1">0.05</td><td align="left" valign="top" rowspan="1" colspan="1">0.04</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td><td align="left" valign="top" rowspan="1" colspan="1">0.02</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Opioids<xref rid="dar14008-note-0017" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">0.94</td><td align="left" valign="top" rowspan="1" colspan="1">0.94</td><td align="left" valign="top" rowspan="1" colspan="1">0.94</td><td align="left" valign="top" rowspan="1" colspan="1">0.94</td><td align="left" valign="top" rowspan="1" colspan="1">0.94</td><td align="left" valign="top" rowspan="1" colspan="1">0.94</td><td align="left" valign="top" rowspan="1" colspan="1">0.89</td><td align="left" valign="top" rowspan="1" colspan="1">0.89</td><td align="left" valign="top" rowspan="1" colspan="1">0.89</td><td align="left" valign="top" rowspan="1" colspan="1">0.89</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">High</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Alcohol<xref rid="dar14008-note-0016" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">0.22</td><td align="left" valign="top" rowspan="1" colspan="1">1.83</td><td align="left" valign="top" rowspan="1" colspan="1">4.56</td><td align="left" valign="top" rowspan="1" colspan="1">4.78</td><td align="left" valign="top" rowspan="1" colspan="1">4.77</td><td align="left" valign="top" rowspan="1" colspan="1">4.34</td><td align="left" valign="top" rowspan="1" colspan="1">4.16</td><td align="left" valign="top" rowspan="1" colspan="1">3.50</td><td align="left" valign="top" rowspan="1" colspan="1">3.20</td><td align="left" valign="top" rowspan="1" colspan="1">2.66</td><td align="left" valign="top" rowspan="1" colspan="1">2.33</td><td align="left" valign="top" rowspan="1" colspan="1">1.91</td><td align="left" valign="top" rowspan="1" colspan="1">1.65</td><td align="left" valign="top" rowspan="1" colspan="1">1.50</td><td align="left" valign="top" rowspan="1" colspan="1">1.57</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cannabis<xref rid="dar14008-note-0016" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">0.28</td><td align="left" valign="top" rowspan="1" colspan="1">2.76</td><td align="left" valign="top" rowspan="1" colspan="1">2.99</td><td align="left" valign="top" rowspan="1" colspan="1">1.84</td><td align="left" valign="top" rowspan="1" colspan="1">1.20</td><td align="left" valign="top" rowspan="1" colspan="1">0.81</td><td align="left" valign="top" rowspan="1" colspan="1">0.62</td><td align="left" valign="top" rowspan="1" colspan="1">0.49</td><td align="left" valign="top" rowspan="1" colspan="1">0.36</td><td align="left" valign="top" rowspan="1" colspan="1">0.24</td><td align="left" valign="top" rowspan="1" colspan="1">0.16</td><td align="left" valign="top" rowspan="1" colspan="1">0.11</td><td align="left" valign="top" rowspan="1" colspan="1">0.07</td><td align="left" valign="top" rowspan="1" colspan="1">0.05</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Amphet<xref rid="dar14008-note-0016" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">0.00</td><td align="left" valign="top" rowspan="1" colspan="1">0.63</td><td align="left" valign="top" rowspan="1" colspan="1">2.78</td><td align="left" valign="top" rowspan="1" colspan="1">2.81</td><td align="left" valign="top" rowspan="1" colspan="1">1.69</td><td align="left" valign="top" rowspan="1" colspan="1">1.02</td><td align="left" valign="top" rowspan="1" colspan="1">0.64</td><td align="left" valign="top" rowspan="1" colspan="1">0.34</td><td align="left" valign="top" rowspan="1" colspan="1">0.18</td><td align="left" valign="top" rowspan="1" colspan="1">0.11</td><td align="left" valign="top" rowspan="1" colspan="1">0.08</td><td align="left" valign="top" rowspan="1" colspan="1">0.06</td><td align="left" valign="top" rowspan="1" colspan="1">0.04</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td><td align="left" valign="top" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Opioids<xref rid="dar14008-note-0017" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">1.00</td><td align="left" valign="top" rowspan="1" colspan="1">1.00</td><td align="left" valign="top" rowspan="1" colspan="1">1.00</td><td align="left" valign="top" rowspan="1" colspan="1">1.00</td><td align="left" valign="top" rowspan="1" colspan="1">1.00</td><td align="left" valign="top" rowspan="1" colspan="1">1.00</td><td align="left" valign="top" rowspan="1" colspan="1">0.97</td><td align="left" valign="top" rowspan="1" colspan="1">0.97</td><td align="left" valign="top" rowspan="1" colspan="1">0.97</td><td align="left" valign="top" rowspan="1" colspan="1">0.97</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot id="dar14008-ntgp-0008"><fn id="dar14008-note-0016"><label>
<sup>a</sup>
</label><p>Sourced from the Global Burden of Disease, (2021) <xref rid="dar14008-bib-0031" ref-type="bibr">31</xref>.</p></fn><fn id="dar14008-note-0017"><label>
<sup>b</sup>
</label><p>Sourced from Downing et al. (2023) <xref rid="dar14008-bib-0033" ref-type="bibr">33</xref>.</p></fn></table-wrap-foot></table-wrap></sec><sec id="dar14008-sec-0019"><title>NATIONAL STUDY OF MENTAL HEALTH AND WELLBEING 2020&#8211;2022 DATA, DRAWN FROM THE AUSTRALIAN BUREAU OF STATISTICS TABLE BUILDER</title><table-wrap position="anchor" id="dar14008-tbl-0010" content-type="TABLE" orientation="portrait"><label>TABLE A2</label><caption><p>Perceived need for mental health services by people with a substance use disorder, National Study of Mental Health and Wellbeing 2020&#8211;2022 <xref rid="dar14008-bib-0014" ref-type="bibr">14</xref>.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Response</th><th align="left" valign="bottom" rowspan="1" colspan="1">Alcohol use disorder (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Alcohol dependence (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Drug dependence<xref rid="dar14008-note-0018" ref-type="table-fn">
<sup>a</sup>
</xref> (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Substance use disorder (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Substance dependence (%)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Need fully met</td><td align="left" valign="top" rowspan="1" colspan="1">16.4</td><td align="left" valign="top" rowspan="1" colspan="1">17.9</td><td align="left" valign="top" rowspan="1" colspan="1">12.7<xref rid="dar14008-note-0020" ref-type="table-fn">
<sup>c</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">15.2</td><td align="left" valign="top" rowspan="1" colspan="1">18.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Need partially met</td><td align="left" valign="top" rowspan="1" colspan="1">21.3</td><td align="left" valign="top" rowspan="1" colspan="1">29.8</td><td align="left" valign="top" rowspan="1" colspan="1">47.7</td><td align="left" valign="top" rowspan="1" colspan="1">24.8</td><td align="left" valign="top" rowspan="1" colspan="1">37.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Need not met</td><td align="left" valign="top" rowspan="1" colspan="1">9.9</td><td align="left" valign="top" rowspan="1" colspan="1">11.0</td><td align="left" valign="top" rowspan="1" colspan="1">8.8<xref rid="dar14008-note-0019" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">10.0</td><td align="left" valign="top" rowspan="1" colspan="1">9.7</td></tr><tr><td align="left" style="background-color:#D9D9D9" valign="top" rowspan="1" colspan="1">No need</td><td align="left" style="background-color:#D9D9D9" valign="top" rowspan="1" colspan="1">51.8</td><td align="left" style="background-color:#D9D9D9" valign="top" rowspan="1" colspan="1">43.0</td><td align="left" style="background-color:#D9D9D9" valign="top" rowspan="1" colspan="1">31.4<xref rid="dar14008-note-0019" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td align="left" style="background-color:#D9D9D9" valign="top" rowspan="1" colspan="1">50.4</td><td align="left" style="background-color:#D9D9D9" valign="top" rowspan="1" colspan="1">35.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Not known</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Refused</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td><td align="left" valign="top" rowspan="1" colspan="1">0.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="left" valign="top" rowspan="1" colspan="1">100.0</td><td align="left" valign="top" rowspan="1" colspan="1">100.0</td><td align="left" valign="top" rowspan="1" colspan="1">100.0</td><td align="left" valign="top" rowspan="1" colspan="1">100.0</td><td align="left" valign="top" rowspan="1" colspan="1">100.0</td></tr></tbody></table><table-wrap-foot id="dar14008-ntgp-0009"><fn id="dar14008-note-0018"><label>
<sup>a</sup>
</label><p>No category is provided for any drug use disorder.</p></fn><fn id="dar14008-note-0019"><label>
<sup>b</sup>
</label><p>Use with caution.</p></fn><fn id="dar14008-note-0020"><label>
<sup>c</sup>
</label><p>Too unreliable to use.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="dar14008-tbl-0011" content-type="TABLE" orientation="portrait"><label>TABLE A3</label><caption><p>Proportion of people with substance use disorders who accessed an alcohol and other drug service in the past year, National Study of Mental Health and Wellbeing 2020&#8211;2022 <xref rid="dar14008-bib-0014" ref-type="bibr">14</xref>.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th rowspan="2" align="left" valign="bottom" colspan="1">Diagnosis</th><th colspan="4" align="left" valign="bottom" rowspan="1">Accessed a professional treatment for alcohand other drugs?</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Yes (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">No (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">NA/unknown (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Total (%)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcohol dependence</td><td align="left" valign="top" rowspan="1" colspan="1">13.7</td><td align="left" valign="top" rowspan="1" colspan="1">33.4</td><td align="left" valign="top" rowspan="1" colspan="1">54.4</td><td align="left" valign="top" rowspan="1" colspan="1">100</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcohol abuse</td><td align="left" valign="top" rowspan="1" colspan="1">2.0</td><td align="left" valign="top" rowspan="1" colspan="1">19.7</td><td align="left" valign="top" rowspan="1" colspan="1">78.8</td><td align="left" valign="top" rowspan="1" colspan="1">100</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcohol use disorder</td><td align="left" valign="top" rowspan="1" colspan="1">7.1</td><td align="left" valign="top" rowspan="1" colspan="1">23.9</td><td align="left" valign="top" rowspan="1" colspan="1">68.0</td><td align="left" valign="top" rowspan="1" colspan="1">100</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Drug dependence<xref rid="dar14008-note-0021" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">20.0</td><td align="left" valign="top" rowspan="1" colspan="1">45.0</td><td align="left" valign="top" rowspan="1" colspan="1">32.6</td><td align="left" valign="top" rowspan="1" colspan="1">100</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Drug abuse<xref rid="dar14008-note-0021" ref-type="table-fn">
<sup>a</sup>
</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">7.8</td><td align="left" valign="top" rowspan="1" colspan="1">22.2</td><td align="left" valign="top" rowspan="1" colspan="1">62.8</td><td align="left" valign="top" rowspan="1" colspan="1">100</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Substance dependence</td><td align="left" valign="top" rowspan="1" colspan="1">17.5</td><td align="left" valign="top" rowspan="1" colspan="1">32.9</td><td align="left" valign="top" rowspan="1" colspan="1">48.8</td><td align="left" valign="top" rowspan="1" colspan="1">100</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Substance abuse</td><td align="left" valign="top" rowspan="1" colspan="1">3.5</td><td align="left" valign="top" rowspan="1" colspan="1">19.8</td><td align="left" valign="top" rowspan="1" colspan="1">76.3</td><td align="left" valign="top" rowspan="1" colspan="1">100</td></tr><tr><td align="left" style="background-color:#D9D9D9" valign="top" rowspan="1" colspan="1">Any substance use disorder</td><td align="left" style="background-color:#D9D9D9" valign="top" rowspan="1" colspan="1">9.5</td><td align="left" style="background-color:#D9D9D9" valign="top" rowspan="1" colspan="1">26.0</td><td align="left" style="background-color:#D9D9D9" valign="top" rowspan="1" colspan="1">65.2</td><td align="left" style="background-color:#D9D9D9" valign="top" rowspan="1" colspan="1">100</td></tr></tbody></table><table-wrap-foot id="dar14008-ntgp-0010"><fn id="dar14008-note-0021"><label>
<sup>a</sup>
</label><p>No category is provided for any drug use disorder. Abbreviation: NA, not applicable.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="dar14008-tbl-0012" content-type="TABLE" orientation="portrait"><label>TABLE A4</label><caption><p>Proportion of people with a substance use disorder who reported accessing a mental or physical health professional in the past year, National Study of Mental Health and Wellbeing 2020&#8211;2022 <xref rid="dar14008-bib-0014" ref-type="bibr">14</xref>.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Type of health professional</th><th align="left" valign="bottom" rowspan="1" colspan="1">Alcohol dependence (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Any alcohol use disorder (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Drug dependence (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Substance dependence (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Any substance use disorder (%)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Health professionals (GP, specialist doctor, surgeon, other)</td><td align="left" valign="top" rowspan="1" colspan="1">42.1</td><td align="left" valign="top" rowspan="1" colspan="1">31.0</td><td align="left" valign="top" rowspan="1" colspan="1">47.1*</td><td align="left" valign="top" rowspan="1" colspan="1">44.2</td><td align="left" valign="top" rowspan="1" colspan="1">34.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mental health professionals (psychiatrist, psychologist, mental health nurse, other)</td><td align="left" valign="top" rowspan="1" colspan="1">35.9</td><td align="left" valign="top" rowspan="1" colspan="1">30.2</td><td align="left" valign="top" rowspan="1" colspan="1">44.9</td><td align="left" valign="top" rowspan="1" colspan="1">41.1</td><td align="left" valign="top" rowspan="1" colspan="1">31.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">None</td><td align="left" valign="top" rowspan="1" colspan="1">52.2</td><td align="left" valign="top" rowspan="1" colspan="1">61.2</td><td align="left" valign="top" rowspan="1" colspan="1">37.6</td><td align="left" valign="top" rowspan="1" colspan="1">42.9</td><td align="left" valign="top" rowspan="1" colspan="1">58.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="left" valign="top" rowspan="1" colspan="1">100.0</td><td align="left" valign="top" rowspan="1" colspan="1">100.0</td><td align="left" valign="top" rowspan="1" colspan="1">100.0</td><td align="left" valign="top" rowspan="1" colspan="1">100.0</td><td align="left" valign="top" rowspan="1" colspan="1">100.0</td></tr></tbody></table><table-wrap-foot id="dar14008-ntgp-8010"><fn id="dar14008-note-8021"><p>Abbreviation: GP, general practitioner.</p></fn></table-wrap-foot></table-wrap></sec><sec id="dar14008-sec-0020"><title>DATA USED TO INFORM THE ESTIMATED NUMBER OF PEOPLE WHO SHOULD RECEIVE TREATMENT</title><table-wrap position="anchor" id="dar14008-tbl-0013" content-type="TABLE" orientation="portrait"><label>TABLE A5</label><caption><p>Proportion of people with a substance use disorder who should receive treatment, by drug type.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Drug type</th><th align="left" valign="bottom" rowspan="1" colspan="1">Proportion to treat (%)</th><th align="left" valign="bottom" rowspan="1" colspan="1">Sources</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcohol</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">Mellor et al., 2019; NSMHWB; previous expert reference groups for DASPM</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cannabis</td><td align="left" valign="top" rowspan="1" colspan="1">40</td><td align="left" valign="top" rowspan="1" colspan="1">Feingold et al., 2015; van der Pol et al., 2015; Kelly et al., 2017; Stea et al., 2015; NSMHWB; previous expert reference groups for DASPM</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Methamphetamine</td><td align="left" valign="top" rowspan="1" colspan="1">75</td><td align="left" valign="top" rowspan="1" colspan="1">Quinn et al. (2016); previous expert reference groups for DASPM</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Opioids</td><td align="left" valign="top" rowspan="1" colspan="1">90</td><td align="left" valign="top" rowspan="1" colspan="1">Kelly et al., 2017; Fleury et al., 2016; Previous expert reference groups for DASPM</td></tr></tbody></table><table-wrap-foot id="dar14008-ntgp-0011"><fn id="dar14008-note-0022"><p>Abbreviations: NSMWB, National Study of Mental Health and Wellbeing; DASPM, Drug and Alcohol Services Planning Model.</p></fn></table-wrap-foot></table-wrap></sec><sec id="dar14008-sec-0021"><title>DATA USED TO INFORM ESTIMATED NUMBER OF PEOPLE RECEIVING ALCOHOL AND OTHER DRUG TREATMENT IN AUSTRALIA</title><table-wrap position="anchor" id="dar14008-tbl-0014" content-type="TABLE" orientation="portrait"><label>TABLE A6</label><caption><p>Number of people receiving treatment in the AODTS&#8208;NMDS and NOPSAD, 2022/2023.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Drug type</th><th align="left" valign="bottom" rowspan="1" colspan="1">AODTS&#8208;NMDS</th><th align="left" valign="bottom" rowspan="1" colspan="1">NOPSAD</th><th align="left" valign="bottom" rowspan="1" colspan="1">Total</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Alcohol</td><td align="left" valign="top" rowspan="1" colspan="1">40,083</td><td align="left" valign="top" rowspan="1" colspan="1">&#8208;</td><td align="left" valign="top" rowspan="1" colspan="1">40,083</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cannabis</td><td align="left" valign="top" rowspan="1" colspan="1">24,017</td><td align="left" valign="top" rowspan="1" colspan="1">&#8208;</td><td align="left" valign="top" rowspan="1" colspan="1">24,017</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Methamphetamine</td><td align="left" valign="top" rowspan="1" colspan="1">22,870</td><td align="left" valign="top" rowspan="1" colspan="1">&#8208;</td><td align="left" valign="top" rowspan="1" colspan="1">22,870</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Opioids</td><td align="left" valign="top" rowspan="1" colspan="1">5579</td><td align="left" valign="top" rowspan="1" colspan="1">55,741</td><td align="left" valign="top" rowspan="1" colspan="1">61,320</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total</td><td align="left" valign="top" rowspan="1" colspan="1">92,548</td><td align="left" valign="top" rowspan="1" colspan="1">&#8208;</td><td align="left" valign="top" rowspan="1" colspan="1">148,289</td></tr></tbody></table><table-wrap-foot id="dar14008-ntgp-0012"><fn id="dar14008-note-0023"><p>Abbreviations: AODTS&#8208;NMDS, Alcohol and Other Drug Treatment Services National Minimum Dataset; NOPSAD, National Opioid Pharmacotherapy Statistics Annual Dataset.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="dar14008-tbl-0015" content-type="TABLE" orientation="portrait"><label>TABLE A7</label><caption><p>Calculations of the total number of clients receiving alcohol and other drug treatment in all datasets, derived from Chalmers, Ritter [<xref rid="dar14008-bib-0020" ref-type="bibr">20</xref>].</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Treatment provider</th><th align="left" valign="bottom" rowspan="1" colspan="1">Number of people<xref rid="dar14008-note-0025" ref-type="table-fn">
<sup>a</sup>
</xref>
</th><th align="left" valign="bottom" rowspan="1" colspan="1">Low estimate (running total)</th><th align="left" valign="bottom" rowspan="1" colspan="1">High estimate (running total)<xref rid="dar14008-note-0026" ref-type="table-fn">
<sup>b</sup>
</xref>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Government funded specialist AOD treatment services</td><td align="left" valign="top" rowspan="1" colspan="1">97,467</td><td align="left" valign="top" rowspan="1" colspan="1">97,467</td><td align="left" valign="top" rowspan="1" colspan="1">97,467</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Opioid agonist treatment</td><td align="left" valign="top" rowspan="1" colspan="1">+50,071</td><td align="left" valign="top" rowspan="1" colspan="1">130,032</td><td align="left" valign="top" rowspan="1" colspan="1">130,032</td></tr><tr><td align="left" style="background-color:#E8E8E8" valign="top" rowspan="1" colspan="1">Total from two main datasets</td><td align="left" style="background-color:#E8E8E8" valign="top" rowspan="1" colspan="1">&#8208;</td><td align="left" style="background-color:#E8E8E8" valign="top" rowspan="1" colspan="1">130,032</td><td align="left" style="background-color:#E8E8E8" valign="top" rowspan="1" colspan="1">130,032</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Aboriginal Community Controlled Organisations</td><td align="left" valign="top" rowspan="1" colspan="1">+32,564</td><td align="left" valign="top" rowspan="1" colspan="1">138,445</td><td align="left" valign="top" rowspan="1" colspan="1">168,696</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">General practitioners</td><td align="left" valign="top" rowspan="1" colspan="1">+8413&#8211;38,664</td><td align="left" valign="top" rowspan="1" colspan="1">138,445</td><td align="left" valign="top" rowspan="1" colspan="1">168,696</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Inpatient hospitals</td><td align="left" valign="top" rowspan="1" colspan="1">+0</td><td align="left" valign="top" rowspan="1" colspan="1">188,516</td><td align="left" valign="top" rowspan="1" colspan="1">218,767</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mental health services and allied health</td><td align="left" valign="top" rowspan="1" colspan="1">+13,652</td><td align="left" valign="top" rowspan="1" colspan="1">202,168</td><td align="left" valign="top" rowspan="1" colspan="1">232,419</td></tr><tr><td align="left" style="background-color:#E8E8E8" valign="top" rowspan="1" colspan="1">Total from all settings</td><td align="left" style="background-color:#E8E8E8" valign="top" rowspan="1" colspan="1">&#8208;</td><td align="left" style="background-color:#E8E8E8" valign="top" rowspan="1" colspan="1">202,168</td><td align="left" style="background-color:#E8E8E8" valign="top" rowspan="1" colspan="1">232,419</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Multiplier (total from all datasets/total from main datasets)</td><td align="left" valign="top" rowspan="1" colspan="1">&#8208;</td><td align="left" valign="top" rowspan="1" colspan="1">1.56</td><td align="left" valign="top" rowspan="1" colspan="1">1.79<xref rid="dar14008-note-0026" ref-type="table-fn">
<sup>b</sup>
</xref>
</td></tr></tbody></table><table-wrap-foot id="dar14008-ntgp-0013"><fn id="dar14008-note-0024"><p>Abbreviation: AOD, alcohol and other drugs.</p></fn><fn id="dar14008-note-0025"><label>
<sup>a</sup>
</label><p>The number of people to be added varies due to different estimates of episode to client conversion. Estimates of the number of people receiving treatment in multiple datasets have been applied to avoid double counting individuals receiving treatment.</p></fn><fn id="dar14008-note-0026"><label>
<sup>b</sup>
</label><p>High estimate was excluded from our analysis due to an assumption used for episode conversion that did not apply to the current analysis.</p></fn></table-wrap-foot></table-wrap></sec></app></app-group></back></article></pmc-articleset>